BioNTech SE (BNTX -2.47%) is still widely viewed as a COVID-19 vaccine maker, but that picture is quickly changing. The company has quietly built a broad late-stage cancer pipeline spanning multiple promising treatments for different cancer types.
With the stock trading below $100, investors may be overlooking the significant upside the company can deliver by expanding its oncology portfolio.
Image source: Getty Images.
From COVID vaccine maker to multi-product cancer company BioNTech is a very different company following the COVID-19 pandemic, having expanded its oncology portfolio, which now spans multiple cancer types.
That pipeline has moved much further along than many investors realize. BioNTech said it has more than 25 phase 2 and phase 3 oncology trials underway and is targeting 15 phase 3 trials by the end of 2026. It's now approaching the point where several of these programs could potentially become commercial products.
And that brings us to the most important piece of BioNTech's pipeline: pumitamig. The opportunity is broad because the company isn't developing this exciting new drug for just one cancer. Specifically, it's being tested across multiple types of solid tumors, including lung, breast, gastric, and kidney cancers, to name a few.
The company is also combining pumitamig with other therapies rather than treating it as a stand-alone product. Should the trials be successful, the drug could become an overall game changer in cancer therapy.
The late-stage pipeline keeps expanding across tumor types One interesting aspect of BioNTech's pipeline is its novel-novel combination strategy. The company is testing pumitamig alongside other kinds of cancer therapies. Essentially, the goal is to build combinations that attack tumors in different ways.
That matters because BioNTech isn't trying to win with one blockbuster drug alone. Instead, it's positioning itself around a portfolio of cancer medicines that can potentially be combined.
In a recent publication, BioNTech identified at least 17 late-stage data readouts through 2030 and beyond, spanning lung, breast, gastrointestinal, and other cancers. The company sees these programs as building blocks for becoming a multi-product oncology company.
Notably, BioNTech is still developing its nRNA oncology platform. BNT113 is in phase 3 development for HPV16-positive head and neck cancer, while autogene cevumeran is being developed as a personalized cancer vaccine for colorectal, pancreatic, and other cancers.
That means investors don't need every program to succeed, since a diversified pipeline can create significant value if several drugs prove effective as they move toward commercialization. The upside could be even greater if some of those drugs are used for multiple tumor types or in combination with one another.
Partnerships add another layer of support. BioNTech has collaborated with companies such as Bristol Myers Squibb, Duality Biologics, and Genentech, enabling it to share development capabilities across its portfolio.
BioNTech's pivot away from COVID hasn't been painless. Revenue fell by about 60% year over year in its latest quarter, and losses widened as the company poured more money into oncology research, even as it named incoming CEO Guido Oelkers to help steer that transition.
Premium Feature
Moneyball Superscore
70/100
Today's Change
(
-2.47
%) $
-2.35
Current Price
$
92.90
But the good news is that BioNTech's balance sheet gives the company plenty of room to move ahead. The company ended the quarter with more than 16 billion euros in cash and securities, providing a cushion to fund its pipeline while it waits on catalysts, including roughly 600 million euros in Bristol Myers Squibb collaboration revenue expected later this year.
What matters now is what the company's oncology portfolio could become. Investors today are gaining exposure to a deep late-stage oncology pipeline, with multiple cancer drugs that offer real diversification. If pumitamig and other late-stage candidates continue to deliver positive data, BioNTech could be closer to becoming a major oncology player than the market realizes.
And with the stock trading below $100, now could be a compelling entry point for investors willing to look past the COVID-era narrative.
Rocket Lab dosáhl rekordního objemu nevyřízených zakázek ve výši 2,36 mld. USD, což představuje meziroční nárůst o 137 %. Stifel ponechal doporučení „Buy“ a cílovou cenu 150 USD, což implikuje růstový potenciál 108,6 %.
Rocket Lab sits more than 50% below its 52-week high after a brutal stretch of dilution and missed earnings, yet one Wall Street analyst just reiterated a target that implies the stock doubles from here. The question is whether a…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) currently trades at $71.92. Wall Street’s average price target is $109.15, which implies 51.8% upside.
Rocket Lab flies the Electron rocket. It runs HASTE hypersonic test missions, builds spacecraft and components, and is finishing its Neutron medium-lift reusable rocket. Defense spending is the main draw. The Space Force budget requests $7.8 billion for space access. Rocket Lab is listed as a prime contractor on both national security launch programs.
The high end of the target range is even further away. Stifel’s Erik Rasmussen has a Street-high $150 target and a reiterated Buy rating. That target implies 108.6% upside, so he expects the stock to more than double.
Dilution and the Iridium Deal Pulled Rocket Lab Off Its Highs Dilution did the most damage. Rocket Lab sold $1.08 billion of stock through its at-the-market program in the second quarter alone. Part of that money is for the Iridium Communications (NASDAQ:IRDM) acquisition, which is a cash and stock transaction. Management also guided the basic share count to about 641 million. Shares fell 13.78% over three months and now sit 52.4% below the 52-week high of $151.
The earnings report added pressure. Revenue of $234.07M rose 62.0% and beat estimates. The GAAP loss of $0.08 per share missed the -$0.0767 estimate, partly due to $8.58M in deal costs. Guidance calls for adjusted EBITDA loss of $17M to $23M, larger than the quarter’s $8.8 million. Management said the Neutron launch window this year is narrowing. A beta of 2.938 means swings tend to be larger than the market’s.
Analysts Are Banking on Neutron and a $2.36 Billion Backlog Analysts remain bullish. Four rate the stock Strong Buy, 12 rate it Buy, four rate it Hold, and none rate it Sell. Stifel’s thesis rests on three points. Neutron could compete with SpaceX’s Falcon 9; Space Systems brings in more than two-thirds of revenue; defense contracts provide long-term backlog visibility.
Backlog grew 137% to a record $2.36 billion, with about 45.5% converting to revenue within 12 months. Recent wins include a $397M Space Force Flatellite contract and a $266 million award for up to 18 missile-defense launches. Neutron targets $50 to $55 million per launch. The CEO said, “We have absolutely zero issues in selling full price Neutrons pre-test flights.”
The timeline is weak. Management linked positive free cash flow to Neutron’s first successful launch, and Neutron’s debut already slipped to Q4 2026. Iridium brings more than $870 million in annual revenue but closes mid-2027. The stock trades at 62.4 times sales.
Space Peers Fell Too, and Planet Labs Shows the Bigger Gap Shares of AST SpaceMobile (NASDAQ:ASTS) trade at $60.65, down 8.27% over the past month and 16.49% year to date. Its $77.94 target implies 28.5% upside. Ratings are conservative with one Strong Buy, four Buy, seven Hold, one Sell and one Strong Sell.
Planet Labs (NYSE:PL) trades at $17.75 and is down 9.99% year to date. Its $33.40 target implies 88.2% upside. Ratings include one Strong Buy, six Buy, three Hold and one Sell. Its gap is larger than Rocket Lab’s.
Planet Labs has the biggest consensus upside in the group, while Rocket Lab sits in the middle, and only Stifel’s target puts it in doubling territory. Price targets are opinions and come with no guarantee for any of these stocks.
Rocket Lab Beats Its Peers but Lags the S&P 500 At $71.92, Rocket Lab has 51.8% upside to the $109.15 consensus target. The stock bounced 11.92% over the past month but dropped 4.18% in its most recent trading day.
Rocket Lab has gained 3.1% so far this year, and the S&P 500 is up 13.98%. The $69.94 50-day average sits below the $81.50 200-day average, so the longer-term trend still points down.
Neutron’s First Flight Decides Whether $150 Is Realistic The bull case strengthens if Neutron reaches the pad on schedule, flies smoothly and converts that 90+ mission backlog into higher-priced revenue. Positive cash flow comes into view and Iridium adds recurring revenue. If Neutron slips again, the downside case strengthens. Rocket Lab would then be funding Neutron, three acquisitions and ongoing burn, likely through more share issuance.
I are bullish. The backlog and defense demand back up the consensus target, but until Neutron flies, $109.15 is a more realistic marker than $150.
Contact [email protected] for any questions or corrections.
Zakázková kniha společnosti Northrop Grumman dosahuje 2,4násobku tržeb za posledních 12 měsíců a roste o 16 % ročně, přičemž marže volného peněžního toku zůstává stabilní na úrovni 8–9 %.
SummaryNorthrop Grumman is well-positioned amid rising Western defense budgets and strong management under CEO Kathy Warden.NOC fundamentals are robust: a large and growing backlog (2.4x TTM revenue, +16% pa), accelerating revenue growth, stable 8-9% cash flow margins, and declining leverage.Valuation is attractive at under 2x TTM revenue and under 22x TTM unlevered pretax FCF, with technicals suggesting a possible bottom near $426.We rate NOC 'Accumulate,' expecting upside from sector rotation and increased defense spending, with a stop-loss below $426 to manage downside risk.This idea was discussed in more depth with members of my private investing community, Growth Investor Pro. Learn More » John M. Chase/iStock Unreleased via Getty Images
DISCLAIMER: This note is intended for US recipients only and, in particular, is not directed at, nor intended to be relied upon by any UK recipients. Nothing in this note is intended to be investment advice, and neither should it be
17.76K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in NOC over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Společnost Kratos Defense & Security Solutions získala zakázky v hodnotě přes 100 milionů USD na prototypy pro vesmírné zpravodajství, zpracování RF signálů a kybernetické operace.
Key Takeaways KTOS won multiple contracts to develop space intelligence, RF processing and cyber mission applications.KTOS is leveraging its RF technology, KnownSpace Network and cybersecurity expertise across emerging missions.KTOS is combining RF sensing, analytics and cybersecurity to support broader space and cyber operations. Kratos Defense & Security Solutions, Inc. (KTOS - Free Report) is expanding its space and cyber capabilities as demand grows for technologies that convert radio-frequency (RF) data into actionable intelligence. In October 2026, the company announced multiple contracts totaling more than $100 million to develop prototype mission applications and cyber capabilities supporting space intelligence, RF signal collection and processing, operational intelligence, electronic warfare and offensive cyber operations.
A key growth opportunity is Kratos’ ability to build new mission applications around its existing RF technology. The company’s KnownSpace Network includes more than 190 strategically placed sensors worldwide, while its field-portable KnownSpace Recon+ terminals support space domain awareness. Its software, analytics and expertise in RF, signal processing, cybersecurity and software development provide a foundation for addressing emerging space and cyber requirements.
This strategy is supported by significant investment in Kratos’ Space, Satellite and Cyber business. The company has invested approximately $315 million in its Space, Satellite and Cyber business since 2019 through internally funded R&D, software development and capital expenditures. These investments have focused largely on satellite command, control and communications systems and global space domain awareness.
The latest awards could enable Kratos to reuse its existing technologies across multiple mission requirements, potentially reducing the need to develop capabilities from scratch. By combining RF sensing, signal processing, software, analytics and cybersecurity, the company is building a broader technology base that could support additional opportunities across space and cyber operations.
Companies Expanding Space and Cyber Mission CapabilitiesThe growing focus on space-based intelligence and cyber capabilities is encouraging defense companies to expand technologies for collecting, processing and using mission data. L3Harris Technologies, Inc. (LHX - Free Report) and Northrop Grumman Corporation (NOC - Free Report) are also developing capabilities for space and cyber missions.
L3Harris Technologies is expanding space-based sensing, communications and cyber capabilities that support intelligence, surveillance and national security missions.
Northrop Grumman is developing space and cyber technologies that support satellite operations, intelligence gathering and secure mission networks.
Earnings Estimates for KTOS StockThe Zacks Consensus Estimate for 2026 and 2027 earnings per share suggests year-over-year growth of 50.91% and 37.06%, respectively.
Image Source: Zacks Investment Research
KTOS Stock Is Trading at a DiscountKratos is trading at a discount relative to the industry, with a forward 12-month price-to-sales of 3.75X compared with the industry average of 7.1X.
Image Source: Zacks Investment Research
KTOS Stock Price PerformanceOver the past three months, Kratos’ shares have fallen 14.1% compared with the industry’s 16.1% decline.
Image Source: Zacks Investment Research
KTOS’ Zacks RankKratos currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Xcel Energy prodá své plynárenské a elektrárenské aktivity v Michiganu společnostem SEMCO ENERGY Gas Company a UPPCO; transakce by měla být po získání potřebných schválení dokončena v roce 2027.
Key Takeaways Xcel Energy plans to sell its Michigan gas and electric operations, with the deal expected to close in 2027.XEL's $60 billion investment plan targets 11% annual rate base growth and 6-8% or higher yearly EPS growth.Rising data center demand supports nearly 5% annual retail electricity sales growth for XEL through 2030. Xcel Energy (XEL - Free Report) announced an agreement to sell its Michigan natural gas operations to SEMCO ENERGY Gas Company and electric operations to Upper Peninsula Power Company (“UPPCO”). The transaction involves 6,000 natural gas customers and 9,000 electric customers across Gogebic and Ontonagon counties. The divestiture is subject to state and federal regulatory approvals and expected to close in 2027.
The proposed divestiture is expected to streamline Xcel Energy’s operations and improve capital allocation by allowing greater focus on its core utility markets. This move could support infrastructure modernization, enhance grid reliability and help meet rising electricity demand, strengthening the company’s long-term growth prospects.
Xcel Energy’s proposed divestiture could enhance financial flexibility and operational efficiency by allowing it to focus investments on the core service territories. This strategic move may support grid modernization, efficient capital allocation and regulated rate base expansion, strengthening XEL’s long-term earnings growth prospects, subject to regulatory approvals.
Recently, another utility, Suncor Energy (SU - Free Report) , planned an offshore asset divestiture for $1.2 billion in upfront cash, which will strengthen financial flexibility and reduce future liabilities. This transaction allows Suncor to focus investments on its core, long-life oil sands assets, improve capital allocation and support free cash flow growth, enhancing long-term profitability and shareholder returns.
Robust Investment Plan Fuels Long-Term GrowthXcel Energy plans to invest $60 billion during 2026-2030, with more than $10 billion in additional investment opportunities. These investments in generation, transmission and distribution infrastructure are expected to drive approximately 11% annual regulated rate base growth through 2030, supporting the company's long-term earnings growth and financial performance.
Xcel Energy expects retail electricity sales to grow nearly 5% annually through 2030, supported by rising data center demand and industrial expansion. With nearly 4 gigawatts (GW) of data center capacity targeted for contracting by 2027, the company anticipates 6-8% or higher annual EPS growth, strengthening its long-term investment appeal.
Rising AI Data Center Demand Fuels Electric Utility GrowthGrowing electricity demand from AI-powered data centers is creating significant long-term growth opportunities for electric utilities. The increasing need for uninterrupted power supply is driving investments in new generation facilities, transmission upgrades and grid modernization. These capital expenditures are likely to strengthen regulated rate bases, boost revenues and support steady earnings growth, enhancing the industry's long-term investment prospects.
Utilities like Dominion Energy (D - Free Report) and FirstEnergy (FE - Free Report) are benefiting from accelerating electricity demand driven by AI-powered data centers. Dominion Energy Virginia had approximately 53.8 GW of contracted data center capacity as of July 2026, supporting its $65 billion investment plan through 2030.
Meanwhile, FirstEnergy's data center contracted load and pipeline reached 24.8 GW in second-quarter 2026, reinforcing its $36 billion Energize365 investment program and long-term growth prospects.
XEL’s Price PerformanceIn the past six months, Xcel Energy’s shares have lost 12.5% compared with its industry's decline of 13.6%.
Price Performance (Six months)
Image Source: Zacks Investment Research
Key Takeaways WTW's organic revenues grew 5% in the second quarter, with Risk & Broking leading at 7% growth. Specialization, client retention and technology solutions are helping WTW offset declining insurance rates. HWC grew 4%, while delayed activity boosted R&B, making sustained 5% growth more challenging. Willis Towers Watson Public Limited Company (WTW - Free Report) appears capable of sustaining more than 5% organic growth, but maintaining that pace will depend heavily on Risk & Broking and the company’s ability to offset softer insurance pricing.
WTW’s organic growth remains a key strength, with organic revenue growth reaching 5% in the second quarter of 2026, supported by solid momentum across both major businesses. The biggest support is WTW’s specialization strategy. Although insurance rates continued to decline across most lines, WTW said its specialty offerings are helping it grow through the cycle.
Risk & Broking led the performance with 7% organic growth, driven by new business, strong client retention and double-digit growth across most specialty businesses, while Health, Wealth & Career delivered 4% growth, led by an 8% increase in Health. Insurance Consulting & Technology also grew 6%, helped by software sales and new business wins.
The sustainability of this growth will depend on whether WTW can continue gaining business despite declining insurance rates across most lines. Its specialization strategy, broad specialty offerings, client retention and technology-based solutions provide important offsets to softer pricing. Management continues to expect mid-single-digit organic growth in Risk & Broking and HWC for 2026, suggesting that 5% growth is achievable, although maintaining this pace will require continued new-business wins and strong execution.
However, sustaining 5%+ growth could become more challenging. HWC grew only 4% organically in the second quarter, with Career flat, while R&B's acceleration partly reflected activity that had been delayed earlier in the year. WTW itself continues to guide for mid-single-digit organic growth in both major segments for 2026, suggesting that 5% is achievable but not necessarily a new baseline above that level.
What About Its Peers?Brown & Brown, Inc. (BRO - Free Report) experienced a moderation in organic growth in the second quarter of 2026, reflecting a softer insurance pricing environment and weakness in its Specialty Distribution business. Organic revenues declined 0.7% year over year, while organic revenues, including contingent commissions, increased 0.7%. Despite the near-term pressure, BRO expects organic growth to improve in the second half of 2026, with management targeting 1.5-2.5% growth in Retail and 2-4% in Specialty Distribution, excluding contingents.
Arthur J. Gallagher & Co. (AJG - Free Report) appears well positioned to sustain around 6% organic growth and continue expanding underlying margins even as insurance pricing moderates. AJG witnessed another solid quarter of organic growth across each business and geography. The bigger drivers of Organic growth remain new business, strong client retention, exposure growth and the diversity of the model across P/C, benefits, reinsurance and claims. AJG is also gaining from activity across construction, infrastructure, energy and data centers. AJG projects a total company organic outlook of 6%, brokerage at 5.5% and risk management at 9% for 2026. AJG expects 2026 will be another year of excellent organic growth.
WTW’s Price PerformanceShares of WTW have lost 13.9% in the past year compared with the industry’s decline of 24.7%.
Image Source: Zacks Investment Research
WTW’s UndervaluationThe stock is undervalued compared with its industry. It is currently trading at a price-to-earnings multiple of 13.2, lower than the industry average of 14.07.
Image Source: Zacks Investment Research
Estimate Movement for WTWThe Zacks Consensus Estimate for WTW’s third-quarter 2026 and fourth-quarter 2026 EPS has moved down 0.9% and 0.2%, respectively, in the past 30 days. The same for full-year 2026 and 2027 EPS has moved down 0.1% and 0.08%, respectively, in the past 30 days.
Wolfspeed získal podmíněné schválení od amerického ministerstva války pro úvěr až ve výši 1,5 miliardy USD se splatností 30 let; dohoda ještě vyžaduje konečné schválení.
Wolfspeed Inc (NYSE:WOLF) shares opened 11% higher on Thursday morning after the chipmaker said the US Department of War had conditionally agreed to lend it up to $1.5 billion over 30 years.
The proposed financing would give the department warrants to purchase up to 7.5% of Wolfspeed’s fully diluted equity, providing the company with a potentially significant source of long-term funding.
Shares of Wolfspeed gave up some of its gains as trading went on, with the stock about 1% higher by midmorning.
The company makes silicon carbide chips, which are used in applications requiring high-efficiency power conversion, including electric vehicles, solar inverters and industrial power systems.
Wolfspeed burned $380 million of free cash flow in the year to June 2026 and had $1.8 billion of debt against $1.09 billion of cash and short-term investments.
The proposed loan is not yet final and remains subject to due diligence, definitive agreements, government approvals, appropriations and sign-off from Wolfspeed’s existing lenders.
The financing would be provided through the Department of War’s Office of Strategic Capital and is intended to strengthen Wolfspeed’s financial position and support investments in its technology.
The company plans to use the financing to upgrade its gallium nitride technology for next-generation communications infrastructure and electronic warfare systems and to develop radiation-hardening capabilities.
No Investment Advice
Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) and this website (the Site) on the terms set out in this disclaimer, together with all other terms and conditions, disclaimers and other notices displayed elsewhere on this Site.
It is important for you to know that:
(a) none of the Content is, or is intended to be, general or personal advice
(b) the principal purpose of the Content is to provide factual information only and to comment on news;
(c) the Content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including in respect of any particular security, portfolio of securities, transaction or investment strategy, and must not be relied upon by you as such;
(d) in providing you with the Content, we have not considered your objectives, financial situation or needs; and
(e) you should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
The Content contains data (including but not limited to prices, statistics and calculated information) obtained from a variety of third party sources (Third Party Data). The Company does not make any representation or warranty that any of the Content, including the Third Party Data, will be reliable, accurate or complete. The Company disclaims all responsibility and liability arising in any way from any errors or omissions in the Content, including the Third Party Data, including any loss you may incur in connection with any action or decision made by you in reliance upon the Content or Third Party Data.
In certain circumstances the Company, its related bodies corporate, or their affiliates, may have received, or be entitled to receive, financial or other consideration in connection with providing information about certain entities on the Site, which may include the above Content.
Western Union obnovila partnerství s Publix, díky čemuž budou v zapojených prodejnách Publix na jihovýchodě USA nadále dostupné domácí i mezinárodní převody peněz, platby účtů a poštovní poukázky.
Key Takeaways WU renews a 20-plus-year Publix deal, keeping transfers, bill payments and money orders in stores.WU's North American money transfer revenue fell 9% and transactions slid 5% in Q2 2026.Publix's 1,432 stores and Kentucky expansion could help Western Union reach more customers. The Western Union Company (WU - Free Report) recently renewed its partnership with Publix Super Markets, extending a relationship spanning more than two decades. The agreement allows customers to continue accessing domestic and international money transfers, bill payments and money orders at participating Publix stores across the southeastern United States.
It also creates opportunities for Western Union to reach additional customers as Publix expands into new markets, including Kentucky. Publix currently operates 1,432 stores across eight states, employing more than 260,000 people. WU’s network spanning over 200 countries and territories and supporting 130 currencies underscores the scale of its cross-border operations and the role of retail partnerships in maintaining customer access.
Western Union's North American money transfer revenues declined 9% in second-quarter 2026, while transactions fell 5%. As such, the renewal will likely help Western Union protect its retail distribution network while reaching customers who prefer in-person financial services. Publix's growing presence offers opportunities to generate transactions without establishing standalone branches. Keeping services available across Publix stores could therefore help Western Union defend market share and improve customer retention.
Western Union also works with major retailers, including Kroger, Walmart, Albertsons, Walgreens, H-E-B and Giant Eagle. During its second-quarter earnings call, management said it had renewed major retail contracts despite increased competition, with terms broadly similar to previous agreements. These relationships help Western Union maintain its retail presence and protect existing revenue streams amid declining transaction volumes in the U.S. market.
It is also pursuing acquisitions to expand its reach. Its pending $500 million purchase of Intermex would strengthen its U.S. retail network and presence in Latin American remittance corridors, with management targeting $30 million in annual cost savings within two years of closing. However, the deal remains subject to California regulatory approval and a renewed federal antitrust waiting period.
Price PerformanceWestern Union shares have declined 34.3% in the year-to-date period compared with the 11.7% fall of the industry it belongs to.
Image Source: Zacks Investment Research
Zacks Rank & Key PicksWestern Union currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader payments space are Mastercard Incorporated (MA - Free Report) , PayPal Holdings, Inc. (PYPL - Free Report) and EVERTEC, Inc. (EVTC - Free Report) , each currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Mastercard’s current-year earnings indicates 17% year-over-year growth. MA has witnessed three upward estimate revisions over the past 60 days against no cuts. The consensus estimate for current-year revenues indicates 13.6% year-over-year growth.
The consensus estimate for PayPal’s current-year earnings indicates 1.3% year-over-year improvement. PYPL witnessed one upward estimate revision over the past 60 days and no downward movement. The consensus estimate for current-year revenues implies a 4.5% year-over-year rise.
The consensus mark for EVERTEC’s current-year earnings indicates 10.5% year-over-year jump. EVTC witnessed two upward estimate revisions over the past 60 days and no downward movement. The consensus estimate for current-year revenues implies a 17% year-over-year growth.
Key Takeaways UNM's Colonial Life adjusted operating income rose 11.9%, while premium income increased 3.3% to $477.4M. Sales grew 6%, while a lower 46.7% benefit ratio reflected favorable claims in key products. Colonial Life's 19.4% ROE and higher investment income support its role as an earnings growth engine. Unum Group’s (UNM - Free Report) Colonial Life could remain an important growth and earnings engine, though the pace of growth will likely depend on sustained sales momentum, persistency and favorable claims experience.
In the second quarter of 2026, Colonial Life’s adjusted operating income rose 11.9%, while premium income increased 3.3% to $477.4 million. Sales grew 6%, providing a healthy pipeline for future premium growth. The segment also benefited from a lower 46.7% benefit ratio, down from 48.3% a year earlier, due to favorable claims experience in life, cancer and critical illness products.
Another positive is investment income. Colonial Life’s net investment income jumped 17.6% to $50.1 million, helped by higher yields and increased allocation of investment income. Adjusted operating ROE reached 19.4%, highlighting the segment's strong profitability.
Technology and distribution could provide additional support. Management said more than 70% of Colonial Life's 12,000-plus agents use Agent Assist, its proprietary agent productivity platform. Greater adoption could improve agent productivity and help support sales growth.
However, investors should watch persistency, which was 78.2% in the first half of 2026 versus 78.5% a year earlier. The relatively modest premium growth also suggests that stronger sales will need to translate into sustained in-force growth to keep Colonial Life's earnings trajectory intact.
Colonial Life currently has several favorable ingredients—solid sales growth, strong claims experience, higher investment income, stable persistency and high ROE. If UNM can maintain these trends, Colonial Life can remain a key contributor to earnings growth and help offset pressure from weaker International results and the Closed Block.
What About Its Peers?Aflac Incorporated’s (AFL - Free Report) U.S. benefits business has the potential to become a more important growth contributor, supported by expanding demand for group voluntary benefits, dental and vision products. In the second quarter of 2026, earned premiums from group products, including group life, absence and disability, dental and vision, and group voluntary benefits, increased 13%, highlighting solid demand. Management expects U.S. net earned premiums to witness a 3-6% CAGR from 2025 to 2027, although 2026 growth is expected to come in slightly below that range. With employers increasingly using voluntary benefits to enhance employee offerings while controlling benefit costs, Aflac's broad distribution network and supplemental products could support steady organic growth.
MetLife, Inc.’s (MET - Free Report) Group Benefits business is emerging as a key growth and earnings contributor, supported by solid premium growth, favorable underwriting trends and improving business volumes. In the second quarter of 2026, Group Benefits adjusted earnings increased strongly, aided by higher premiums and improved underwriting performance. Continued demand for employer-sponsored life, disability and dental benefits, along with higher enrollment and strong customer retention, could support further growth. Investors, however, will want to assess whether favorable claims experience can be sustained as pricing conditions evolve and whether premium growth can translate into durable earnings expansion.
UNM’s Price PerformanceShares of UNM have gained 18.6% in the year-to-date period, outperforming the industry.
Image Source: Zacks Investment Research
UNM’s UndervaluationThe stock is undervalued compared with its industry. Its forward price-to-book value of 1.37X is lower than the industry average of 1.66X. It carries a Value Score of B.
Image Source: Zacks Investment Research
Estimate Movement for UNMThe Zacks Consensus Estimate for UNM’s third-quarter and fourth-quarter 2026 EPS has both moved down 0.9% in the past 60 days. The same for the full-year 2026 and 2027 EPS has moved up 0.2% and down 0.9%, respectively, in the past 60 days.
Advokátní kancelář Glancy Prongay Wolke & Rotter vyšetřuje společnost Lennar kvůli možnému porušení federálních zákonů o cenných papírech. Akcie 5. října 2026 klesly o 6,73 %.
Securities Fraud Investigation Into Lennar Corporation (LEN) Announced -- Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Lennar Corporation (“Lennar” or the “Company”) (NYSE: LEN) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON LENNAR CORPORATION (LEN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
What Happened?
On October 2, 2026, Hunterbrook Media published a report alleging, among other things, that Lennar Corporation reported 20,840 home deliveries for the third quarter against guidance of 20,500 to 21,500 deliveries. According to the report, Lennar Corporation exceeded the low end of its third-quarter delivery guidance by 340 homes only because Millrose Properties, Inc. purchased approximately 356 Lennar Corporation homes in the final week of the quarter.
On this news, Lennar's stock fell $5.37 or 6.73%, to close at $74.44 on October 5, 2026, thereby injuring investors.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles H. Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
Whistleblower Notice
Persons with non-public information regarding Lennar Corporation should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected].
About Glancy Prongay Wolke & Rotter LLP
Glancy Prongay Wolke & Rotter LLP (“GPWR”) is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. GPWR has been consistently ranked in the Top 50 Securities Class Action Settlements by ISS Securities Class Action Services. In 2018, GPWR was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements.
With four offices across the country, GPWR’s nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPWR’s lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261008691145/en/
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Společnost First Horizon by měla za čtvrtletí končící v září 2026 vykázat zisk 0,53 USD na akcii, což představuje meziroční nárůst o 3,9 %, při výnosech ve výši 889,7 mil. USD.
Wall Street expects a year-over-year increase in earnings on higher revenues when First Horizon National (FHN - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on October 15, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis bank holding company is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of +3.9%.
Revenues are expected to be $889.7 million, up 0.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.67% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for First Horizon?For First Horizon, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.55%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that First Horizon will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that First Horizon would post earnings of $0.52 per share when it actually produced earnings of $0.54, delivering a surprise of +3.85%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
First Horizon doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Společnost Super Micro Computer získala ve čtvrtém čtvrtletí fiskálního roku 2026 nové objednávky v hodnotě více než 60 miliard USD, což podporuje výhled tržeb pro fiskální rok 2027.
Key Takeaways SMCI received more than $60 billion in new orders during fiscal 2026's fourth quarter. SMCI's Enterprise and channel revenues rose 39% year over year in the fourth quarter. SMCI is expanding liquid-cooling solutions as high-performance AI systems generate more heat. Super Micro Computer (SMCI - Free Report) has been at the forefront of the AI infrastructure boom led by worldwide AI investments. Annual spending is surging, and long-term projections suggest that cumulative AI data center and infrastructure spending will double from its current level. SMCI’s large order pipeline supports its fiscal 2027 sales outlook. Super Micro Computer’s fiscal 2026 revenues rose 78% to $39.1 billion.
SMCI has more than $60 billion of new orders received during the fourth quarter of fiscal 2026. The company is benefiting from its emphasis on early availability of new AI systems as a competitive advantage. In fourth-quarter fiscal 2026, the company was shipping volume products across NVIDIA’s GB300 NVL72, HGX B300, B200 NVL4 and RTX 6000 Pro lines. It is also preparing systems based on NVIDIA Vera Rubin, Vera CPU platforms, AMD, the Helios product line and the MI450 Total Solution.
Super Micro Computer is adding enterprise and channel customers. Enterprise and channel revenues represented 31% of fiscal 2026 sales and increased 39% year over year. In fourth-quarter fiscal 2026, the category accounted for 50% of revenue compared with 28% in the prior quarter, as customers upgraded compute, storage and networking infrastructure. SMCI is positioning itself as a one-stop provider for the infrastructure required to build and operate AI factories and modern data centers with its Data Centre Building Block Systems (DCBBS).
The portfolio includes liquid-cooling solutions, such as in-rack coolant distribution units (CDUs), chilled doors and cooling towers. The company says its in-rack CDUs can support cooling capacity of up to 250 kilowatts, while cooling towers can support between 1 and 50 megawatts. Such capabilities are increasingly important as high-performance AI systems generate substantially more heat than conventional computing workloads. Together, these factors make SMCI a solid business right now.
How Competitors Fare Against SMCISMCI is in competition with giants like Hewlett Packard Enterprise (HPE - Free Report) and Dell Technologies (DELL - Free Report) . Hewlett Packard Enterprise is providing enterprises with an integrated AI infrastructure portfolio spanning hardware, software and cloud management.
Hewlett Packard Enterprise combines compute, storage, networking and GreenLake platform with NVIDIA's GPUs, CPUs, networking technologies and AI Enterprise software. Dell Technologies, meanwhile, is pursuing a broader ecosystem strategy through its Dell AI Factory. Rather than focusing solely on servers, Dell is expanding across compute, storage, networking, automation and software. Dell recently introduced PowerEdge R9822 and M9822 servers.
SMCI’s Price Performance, Valuation and EstimatesShares of Super Micro Computer have gained 53.5% year to date compared with the Zacks Computer – Storage Devices industry’s growth of 224.6%.
SMCI YTD Performance Chart
Image Source: Zacks Investment Research
From a valuation standpoint, SMCI is trading at a discount at a forward 12 Month P/S multiple of 0.42X compared with the industry’s P/S multiple of 3.03X.
The Zacks Consensus Estimate for Super Micro Computer’s fiscal 2026 and 2027 earnings implies a year-over-year increase of approximately 20.4% and 17.5%, respectively. Estimates for fiscal 2027 and 2028 earnings have been revised upward in the past 60 days.
Image Source: Zacks Investment Research
Super Micro Computer currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Wall Street expects a year-over-year increase in earnings on higher revenues when The PNC Financial Services Group, Inc (PNC - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 15. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $4.97 per share in its upcoming report, which represents a year-over-year change of +14.3%.
Revenues are expected to be $6.6 billion, up 11.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.06% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for The PNC Financial Services Group?For The PNC Financial Services Group, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.80%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that The PNC Financial Services Group will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that The PNC Financial Services Group would post earnings of $4.51 per share when it actually produced earnings of $4.85, delivering a surprise of +7.54%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
The PNC Financial Services Group appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAnother stock from the Zacks Financial - Investment Bank industry, Bank of America (BAC - Free Report) , is soon expected to post earnings of $1.12 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +5.7%. Revenues for the quarter are expected to be $30.62 billion, up 9% from the year-ago quarter.
The consensus EPS estimate for Bank of America has been revised 0.2% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -0.24%.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that Bank of America will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Independent Bank Corp. by měla za čtvrtletí končící v září 2026 vykázat zisk na akcii ve výši 1,84 USD, což představuje meziroční nárůst o 18,7 %, a výnosy ve výši 258,66 milionu USD.
Wall Street expects a year-over-year increase in earnings on higher revenues when Independent Bank Corp. (INDB - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 15. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis holding company for Rockland Trust is expected to post quarterly earnings of $1.84 per share in its upcoming report, which represents a year-over-year change of +18.7%.
Revenues are expected to be $258.66 million, up 6.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.17% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Independent Bank Corp.?For Independent Bank Corp., the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.90%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Independent Bank Corp. will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Independent Bank Corp. would post earnings of $1.77 per share when it actually produced earnings of $1.70, delivering a surprise of -3.95%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Independent Bank Corp. appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAnother stock from the Zacks Banks - Northeast industry, FB Financial (FBK - Free Report) , is soon expected to post earnings of $1.21 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +13.1%. Revenues for the quarter are expected to be $180.14 million, up 3.6% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for FB Financial has been revised 0.2% down to the current level. Nevertheless, the company now has an Earnings ESP of -1.33%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #2 (Buy), makes it difficult to conclusively predict that FB Financial will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Očekává se, že Commercial Metals za čtvrtletí končící v srpnu 2026 vykáže zisk 1,97 USD na akcii, což představuje meziroční nárůst o 43,8 %, při tržbách ve výši 2,44 miliardy USD.
Wall Street expects a year-over-year increase in earnings on higher revenues when Commercial Metals (CMC - Free Report) reports results for the quarter ended August 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 15. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis manufacturer and recycler of steel and metal products is expected to post quarterly earnings of $1.97 per share in its upcoming report, which represents a year-over-year change of +43.8%.
Revenues are expected to be $2.44 billion, up 15.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.16% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Commercial Metals?For Commercial Metals, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.25%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Commercial Metals will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Commercial Metals would post earnings of $1.6 per share when it actually produced earnings of $1.73, delivering a surprise of +8.13%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Commercial Metals doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Valero Energy (VLO) se obchoduje za 8,95násobek EV/EBITDA oproti průměru odvětví 6,07; levnější těžká ropa a omezené rafinační kapacity podporují marže.
Key Takeaways VLO trades at 8.95x EV/EBITDA versus the industry's 6.07x, but its fundamentals justify the premium.Access to cheaper heavy crude and constrained global refining capacity support VLO's refining margins.VLO gained 161.8% over the past year, backed by a strong balance sheet and upward estimate revisions. Valero Energy Corporation (VLO - Free Report) is currently considered expensive on a relative basis, with the stock trading at an 8.95x trailing 12-month Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization (EV/EBITDA), which is a premium compared with the broader industry average of 6.07x. Two other refiners, Phillips 66 (PSX - Free Report) and Par Pacific Holdings, Inc. (PARR - Free Report) , are currently trading at 12.02x trailing 12-month EV/EBITDA and 3.59x trailing 12-month EV/EBITDA, respectively.
Image Source: Zacks Investment Research
Is the premium valuation justified? Before making investment decisions, one should consider the company's overall business environment and fundamentals.
VLO's Advantageous Position in Heavy Crude Aids It
The Middle East tensions are driving crude oil prices higher, with West Texas Intermediate (“WTI”) trading above $90 per barrel, according to data from Oilprice.com. The high crude price has significantly increased input costs for refiners such as VLO, PSX and PARR. However, unlike many refiners, Valero Energy has a heavy crude advantage, as heavy crude is cheaper than light crude like WTI.
Regarding the company’s access to diverse crude feedstocks, Valero has an advantage because its Gulf Coast refineries can buy crude oil from many low-cost sources, including the United States, Canada and Venezuela. This gives the company more flexibility to purchase cheaper oil, which helps keep refining costs low and can boost profits when competitors have fewer sourcing options.
Constrained Global Refining Capacity is a Boon for VLO?
Global refining capacity is constrained and fuel inventories are low. On the demand side, gasoline, diesel and jet fuel remain resilient. This means people are still driving and flying quite often, while diesel demand suggests transportation, freight, agriculture and industrial activity are still holding up. As a result, with busy refineries and fuel not in abundant supply, refining margins for refiners are quite strong.
With crude prices likely to remain high, investors shouldn’t allocate their money only to exploration and production companies but also to refining players like VLO, even though high crude prices have been increasing refiners’ input costs.
Strong Balance Sheet Provides Support for VLO
The leading refining company ended the June quarter of 2026 with a net debt-to-capitalization of just 11%. It added $2.1 billion to its cash balance during the June quarter, making its financial position even stronger. It also reported $5.3 billion of available liquidity excluding cash, providing significant financial flexibility.
Thus, the company can lean on its balance sheet to combat an uncertain business environment, reflecting its relatively stable business model compared to other players with a weaker balance sheet.
Time to Bet on the Stock?
Valero, with 14 refineries and a combined throughput capacity of roughly 3 million barrels per day, has witnessed upward earnings estimate revisions for 2026 over the past seven days.
Image Source: Zacks Investment Research
All the positive developments are getting reflected in the price chart. Over the past year, VLO jumped 161.8%, outperforming PARR’s 138% surge and PSX’s 107.2% gain. Thus, considering the business backdrop, it’s worth paying a premium for VLO stock, which currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Hlavní účetní společnosti Sunrun Maria Barak prodala 1 771 akcií za průměrnou cenu 7,77 USD, celkem za 13 760,67 USD, aby pokryla daňové povinnosti související s nabytím akciových odměn.
Sunrun Inc. (NASDAQ:RUN – Get Free Report) CAO Maria Barak sold 1,771 shares of the stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $7.77, for a total transaction of $13,760.67. Following the transaction, the chief accounting officer owned 88,262 shares in the company, valued at $685,795.74. The trade was a 1.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Maria Barak also recently made the following trade(s):
On Thursday, July 9th, Maria Barak sold 3,278 shares of Sunrun stock. The stock was sold at an average price of $12.17, for a total transaction of $39,893.26. Sunrun Price Performance Shares of Sunrun stock opened at $7.61 on Thursday. Sunrun Inc. has a 52-week low of $7.42 and a 52-week high of $22.44. The stock has a market capitalization of $1.83 billion, a price-to-earnings ratio of 5.14 and a beta of 2.44. The company has a fifty day moving average of $8.93 and a 200-day moving average of $11.59. The company has a debt-to-equity ratio of 3.34, a quick ratio of 1.00 and a current ratio of 1.42.
Sunrun (NASDAQ:RUN – Get Free Report) last released its earnings results on Wednesday, August 5th. The energy company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.23 by $0.19. The company had revenue of $869.99 million for the quarter, compared to analyst estimates of $746.87 million. Sunrun had a net margin of 11.59% and a return on equity of 9.59%. The firm’s quarterly revenue was up 52.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.07 EPS. Equities research analysts expect that Sunrun Inc. will post 1.19 EPS for the current year. Sunrun News Roundup Here are the key news stories impacting Sunrun this week:
Positive Sentiment: Sunrun’s third-quarter 2026 earnings release is scheduled for after the market closes on November 4, followed by a conference call at 4:30 p.m. ET. The event gives investors a near-term catalyst and an opportunity to assess operating performance, liquidity and outlook. Sunrun Announces Date for Third Quarter 2026 Earnings Report Neutral Sentiment: Sunrun recently gained 2.1% in a prior session, but the stock remains well below its 50-day and 200-day moving averages and is close to its 52-week low, signaling continued investor caution. Sunrun Exceeds Market Returns: Some Facts to Consider Negative Sentiment: Several executives reported stock sales dated October 6, including CEO Mary Powell, CFO Danny Abajian, CAO Maria Barak, CRO Paul Dickson and insider Jeanna Steele. The transactions totaled roughly 68,700 shares, but all were described as sales to satisfy tax obligations from equity vesting. The volume of insider selling may weigh on sentiment, even though it does not necessarily represent discretionary bearish trading. Sunrun CEO Insider Filing Sunrun CFO Insider Filing Negative Sentiment: Sunrun previously set a new one-year low, reinforcing concerns about weak momentum and heightened volatility. The stock’s elevated beta and leverage could amplify reactions to the upcoming earnings report. Sunrun Sets New 1-Year Low Institutional Inflows and Outflows A number of hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP raised its position in Sunrun by 2.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 6,519,053 shares of the energy company’s stock valued at $88,375,000 after purchasing an additional 165,196 shares during the last quarter. Contour Asset Management LLC bought a new stake in shares of Sunrun in the 4th quarter worth approximately $98,010,000. Maple Rock Capital Partners Inc. grew its position in shares of Sunrun by 23.1% in the 2nd quarter. Maple Rock Capital Partners Inc. now owns 3,694,548 shares of the energy company’s stock worth $49,433,000 after buying an additional 692,448 shares during the last quarter. Amundi grew its position in shares of Sunrun by 3.9% in the 2nd quarter. Amundi now owns 3,428,504 shares of the energy company’s stock worth $45,845,000 after buying an additional 127,878 shares during the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of Sunrun during the second quarter valued at approximately $29,953,000. Hedge funds and other institutional investors own 91.69% of the company’s stock.
Wall Street Analyst Weigh In RUN has been the topic of a number of analyst reports. The Goldman Sachs Group decreased their price target on Sunrun from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, September 21st. Wall Street Zen raised Sunrun from a “sell” rating to a “hold” rating in a research note on Saturday, August 15th. TD Cowen cut their target price on shares of Sunrun from $21.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. UBS Group decreased their target price on shares of Sunrun from $23.00 to $20.00 and set a “buy” rating on the stock in a research note on Tuesday, June 16th. Finally, Citigroup lowered their price target on shares of Sunrun from $20.00 to $16.00 and set a “buy” rating for the company in a report on Friday, August 7th. Twelve research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $16.70.
Read Our Latest Analysis on RUN
Sunrun Company Profile (Get Free Report)
Sunrun Inc is a residential solar energy company that designs, installs, owns and maintains solar energy systems for homeowners. The company typically provides electricity through long-term agreements, including solar leases and power purchase agreements, allowing customers to use electricity generated by rooftop solar systems without purchasing the equipment outright.
Sunrun also offers energy storage solutions, including its BrightBox battery system, which can store electricity for use during outages, periods of high demand or when solar generation is unavailable.
Read More Five stocks we like better than Sunrun Skydance Just Became a Media Giant—With an $80 Billion Debt Load Could Velo3D Be the Next Defense Buyout Target? Penguin Solutions Is Soaring as AI Memory Demand Explodes Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Sunrun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunrun and related companies with MarketBeat.com's FREE daily email newsletter.
Glaukos Corporation (NYSE:GKOS) reported three-year trial results for its non-invasive keratoconus treatment while simultaneously securing an exclusive licensing deal to broaden its pipeline of retinal disease therapies.
Long-Term Phase 3 Success For EpioxaThe ophthalmic healthcare firm released positive topline data from its GLK-202-03 extension study evaluating Epioxa, a novel topical therapy for keratoconus.
Keratoconus is a sight-threatening corneal disorder that remains widely undiagnosed and undertreated throughout the patient population.
Designed as an incision-free alternative to traditional corneal cross-linking, the oxygen-supplemented therapy is bioactivated by pulsed UV light and does not require removing the corneal epithelium, helping to lower procedure pain, streamline administration, and speed patient recovery.
The extension trial monitored 38 study eyes across 35 subjects for up to three years following a single Epioxa treatment, with no further medical interventions administered during the follow-up period.
A total of 92% of participant eyes completed the final three-year assessment visit. Treated eyes maintained a 1.9 diopter improvement in maximum corneal curvature from baseline, proving long-term stabilization and flattening of the cornea.
Furthermore, visual outcomes showed strong performance, with 29% of eyes gaining two or more lines of best-corrected visual acuity and 20% gaining three or more lines.
The treatment maintained a clean safety profile with zero serious adverse events, treatment-related adverse events, or therapy-related patient discontinuations.
Retinal Pipeline Expansion Via Licensing DealGlaukos also announced an exclusive licensing agreement with RevOpsis Therapeutics Inc. to develop and commercialize RO-104, a first-in-class tri-specific biologic.
The high-concentration drug candidate targets several conditions, including neovascular age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion.
The therapeutic simultaneously blocks VEGF-A and VEGF-C while inhibiting Ang-2. Preclinical testing in animal models showed superior performance over existing anti-VEGF therapies.
The deal grants Glaukos exclusive rights to leverage the RevMod platform to develop up to four additional retinal biologics. The financial terms of the transaction were not disclosed.
GKOS Price Action: Glaukos shares were down 10.76% at $153.65 at the time of publication on Thursday, according to Benzinga Pro data.
HWG Holdings LP ve třetím čtvrtletí nakoupila 18 117 akcií společnosti Arista Networks za přibližně 3,688 milionu USD; tato pozice tvoří 0,9 % jejího portfolia.
HWG Holdings LP purchased a new position in shares of Arista Networks, Inc. (NYSE:ANET – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 18,117 shares of the technology company’s stock, valued at approximately $3,688,000. Arista Networks makes up about 0.9% of HWG Holdings LP’s investment portfolio, making the stock its 29th biggest holding.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Applied Capital LLC FL bought a new position in Arista Networks during the third quarter worth about $6,005,000. Dominguez Wealth Management Solutions Inc. bought a new stake in shares of Arista Networks in the third quarter worth about $773,000. Elevation Wealth Partners LLC increased its holdings in shares of Arista Networks by 386.7% in the third quarter. Elevation Wealth Partners LLC now owns 1,431 shares of the technology company’s stock worth $291,000 after acquiring an additional 1,137 shares in the last quarter. Retirement Wealth Solutions LLC raised its position in shares of Arista Networks by 890.0% during the third quarter. Retirement Wealth Solutions LLC now owns 297 shares of the technology company’s stock worth $60,000 after purchasing an additional 267 shares during the period. Finally, Cooper Financial Group raised its position in shares of Arista Networks by 36.6% during the third quarter. Cooper Financial Group now owns 17,084 shares of the technology company’s stock worth $3,478,000 after purchasing an additional 4,576 shares during the period. Institutional investors and hedge funds own 82.47% of the company’s stock.
Arista Networks Stock Performance NYSE:ANET opened at $215.71 on Thursday. The stock has a 50-day simple moving average of $196.59 and a 200 day simple moving average of $171.18. Arista Networks, Inc. has a 52-week low of $114.52 and a 52-week high of $217.32. The company has a market cap of $272.06 billion, a PE ratio of 68.05, a PEG ratio of 2.53 and a beta of 1.60.
Arista Networks (NYSE:ANET – Get Free Report) last released its earnings results on Tuesday, August 4th. The technology company reported $1.02 EPS for the quarter, beating the consensus estimate of $0.89 by $0.13. Arista Networks had a return on equity of 30.65% and a net margin of 38.37%.The firm had revenue of $3.04 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same quarter in the previous year, the business posted $0.73 EPS. The business’s quarterly revenue was up 37.7% compared to the same quarter last year. Arista Networks has set its Q3 2026 guidance at 1.060-1.080 EPS. On average, research analysts predict that Arista Networks, Inc. will post 3.74 earnings per share for the current fiscal year. Key Stories Impacting Arista Networks Here are the key news stories impacting Arista Networks this week:
Positive Sentiment: Arista announced an open Ethernet rack-scale portfolio designed for high-density, scale-up and scale-out AI infrastructure. The liquid-cooled solutions use open standards and were developed with partners including AMD, Arm, Broadcom, Meta, Microsoft and Qualcomm, strengthening Arista’s positioning in the fast-growing AI data-center networking market. Arista Announces Rack-Scale Architectures for Scale-Up and Scale-Out AI Fabrics Positive Sentiment: ClearBridge Investments highlighted Arista as an AI infrastructure company with solid execution, a clearer path to AI monetization and raised guidance. The commentary suggests investors are favoring Arista over some higher-momentum semiconductor names. Arista Networks Outperforms AI Infrastructure Peers Positive Sentiment: Earlier analyst actions remain supportive: Bernstein initiated coverage at Outperform, while the broader analyst consensus is Buy with a $231.70 target. Arista’s latest reported quarter also showed strong momentum, including 37.7% year-over-year revenue growth and earnings above expectations. Neutral Sentiment: Arista will report third-quarter 2026 results after the market close on November 3. Investors may be positioning ahead of the release, with attention focused on whether AI-related demand supports the company’s guidance of $1.06-$1.08 in quarterly EPS. Arista Networks Q3 2026 Earnings Date Negative Sentiment: Zacks Research downgraded Arista from Strong Buy to Hold, which may have contributed to profit-taking after the stock’s sharp rally and elevated valuation. Negative Sentiment: A director sold 5,000 shares through a pre-arranged Rule 10b5-1 plan. Although the transaction was scheduled in advance, it adds a modest negative signal for sentiment. Analysts Set New Price Targets Several equities analysts recently issued reports on the company. Erste Group Bank upgraded Arista Networks from a “hold” rating to a “buy” rating in a research report on Wednesday, July 15th. Sanford C. Bernstein assumed coverage on shares of Arista Networks in a research note on Wednesday, September 30th. They issued an “outperform” rating and a $250.00 price target on the stock. Deutsche Bank Aktiengesellschaft started coverage on shares of Arista Networks in a report on Monday, August 31st. They issued a “buy” rating and a $220.00 price target for the company. Jefferies Financial Group set a $250.00 price objective on shares of Arista Networks in a research report on Wednesday, August 5th. Finally, Rosenblatt Securities raised their price objective on shares of Arista Networks from $210.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Arista Networks has an average rating of “Moderate Buy” and an average target price of $231.70.
Get Our Latest Stock Analysis on ANET
Insiders Place Their Bets In related news, CEO Jayshree Ullal sold 62,622 shares of the firm’s stock in a transaction on Friday, September 25th. The shares were sold at an average price of $211.40, for a total value of $13,238,290.80. Following the completion of the transaction, the chief executive officer owned 4,876,972 shares of the company’s stock, valued at approximately $1,030,991,880.80. This trade represents a 1.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Kenneth Duda sold 17,333 shares of Arista Networks stock in a transaction on Monday, September 21st. The shares were sold at an average price of $203.50, for a total transaction of $3,527,265.50. Following the completion of the sale, the insider owned 12,976 shares in the company, valued at $2,640,616. The trade was a 57.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 3,144,894 shares of company stock valued at $631,310,023 over the last 90 days. 2.70% of the stock is currently owned by company insiders.
Arista Networks Company Profile (Free Report)
Arista Networks, Inc develops and sells cloud networking solutions for data centers, campus environments and high-performance computing applications. Its products include Ethernet switches, routers, wireless access points and related networking equipment designed to support cloud computing, artificial intelligence, enterprise and service-provider networks.
The company’s software portfolio includes Arista EOS, its network operating system, and CloudVision, a platform that helps customers manage, automate and monitor network infrastructure.
Further Reading Five stocks we like better than Arista Networks Skydance Just Became a Media Giant—With an $80 Billion Debt Load Could Velo3D Be the Next Defense Buyout Target? Penguin Solutions Is Soaring as AI Memory Demand Explodes Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up Want to see what other hedge funds are holding ANET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arista Networks, Inc. (NYSE:ANET – Free Report).
Receive News & Ratings for Arista Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arista Networks and related companies with MarketBeat.com's FREE daily email newsletter.
Arista Networks představila otevřená ethernetová řešení pro infrastrukturu AI; Etherlink SU-14 podporuje až 144 akcelerátorů na jeden rack a 1 024 XPU napříč několika racky.
Key Takeaways Arista Networks unveiled open Ethernet rack-scale solutions for high-density AI infrastructure.ANETs Etherlink SU-14 supports up to 144 accelerators per rack and 1,024 XPUs across racks.New optics can boost networking capacity to 6.5 Pb/s per rack while supporting advanced cooling. Arista Networks, Inc. (ANET - Free Report) has unveiled a new open Ethernet rack-scale portfolio designed to support high-density artificial intelligence (AI) infrastructure across both scale-up and scale-out environments. Developed with AMD, Arm, Broadcom, d-Matrix, Meta, Microsoft and Qualcomm, the solutions offer cloud and enterprise customers a flexible alternative to proprietary AI systems.
Arista’s latest Etherlink SU-14 architecture extends Ethernet into scale-up environments, supporting up to 144 accelerators in a single rack and up to 1,024 XPUs through cross-rack configurations. It includes orthogonal chassis, cabled backplane and cross-rack designs, allowing customers to choose architectures based on their bandwidth, cooling and scalability needs.
For scale-out AI environments, the company’s rack-scale solutions support technologies such as ESUN, NVIDIA’s NVLink, NVLink Fusion and PCIe. Built on Arista’s Netdi foundation, the platform uses Ultra Ethernet Consortium standards, Multipath Reliable Connection, multi-plane routing, Dynamic Load Balancing and Cluster Load Balancing to improve AI workload performance and token-generation efficiency.
Arista’s rack designs also integrate liquid-cooled 7060EX7 switches with up to 102.4 Tbps of capacity per switch, alongside cooling manifolds, leak detection, rack controllers and backup power systems. The company’s next-generation optics, including XPO and open CPO/NPO, can raise networking capacity from 1.6 Pb/s to 6.5 Pb/s per rack compared with current OSFP-based switches.
As demand for high-performance AI infrastructure accelerates, the launch strengthens Arista’s position in AI networking by combining open Ethernet connectivity, high-density computing and advanced cooling technologies while helping customers reduce data center footprint and avoid proprietary lock-in.
How Are Competitors Advancing in AI Infrastructure?Arista faces competition from Cisco Systems, Inc. (CSCO - Free Report) and NVIDIA Corporation (NVDA - Free Report) . Cisco is expanding its AI infrastructure business through its Secure AI Factory with NVIDIA, which now includes rack-scale systems. The solutions combine AI computing with Cisco’s networking, security and monitoring technologies for businesses and other large-scale AI deployments. The company is using its Nexus and Silicon One technologies to improve data movement across AI systems.
NVIDIA is advancing its AI infrastructure with the Vera Rubin platform, built to support large and complex AI workloads. The company is developing Spectrum-6 Ethernet to improve connectivity and data transfer between GPUs in AI data centers. NVIDIA is working with Amazon Web Services to add millions of GPUs to meet the growing demand for AI computing.
ANET’s Price Performance, Valuation & EstimatesShares of Arista have gained 37.1% over the past year against the industry’’s decline of 4%.
Image Source: Zacks Investment Research
From a valuation standpoint, Arista trades at a forward price-to-sales ratio of 17.88, above the industry average of 4.39.
Image Source: Zacks Investment Research
Earnings estimates for 2026 have remained static at $4.08 over the past 60 days, while the same for 2027 has increased 0.2% to $5.06.
Image Source: Zacks Investment Research
Arista currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
CRH plánuje koupit dánské a finské aktivity společnosti NCC Industry, včetně lomů, asfaltových závodů a recyklačních provozů; transakce má být uzavřena v roce 2027.
Key Takeaways CRH to acquire NCC Industry's Denmark and Finland operations, adding aggregates and recycling capabilities.CRH invested $1.4B across 17 acquisitions through June 2026, supporting its connected portfolio strategy.CRH reaffirmed 2026 adjusted EBITDA guidance and expects another year of margin expansion. CRH plc (CRH - Free Report) is strengthening its aggregates-led growth strategy with the planned acquisition of NCC Industry’s operations in Denmark and Finland, adding scale and capabilities across key Nordic infrastructure markets. The transaction, expected to close in 2027, subject to approvals, includes Denmark’s network of asphalt plants and land- and marine-based aggregates sites, along with high-quality reserves. In Finland, CRH will gain reserve-backed hard-rock quarries, backfilling and recycling operations.
The deal complements CRH’s broader focus on transportation, water and reindustrialization, while expanding its exposure to road, infrastructure and industrial projects in high-growth urban markets. This strategy is already showing traction. In the second quarter of 2026, CRH’s International Solutions revenues rose 5% year over year, while adjusted EBITDA increased 8%, with Europe benefiting from infrastructure investment and reindustrialization.
The Nordic transaction also reinforces CRH’s capital-allocation playbook. Year to date (as of June 30, 2026), the company has invested $1.4 billion across 17 acquisitions spanning aggregates, cementitious materials, roads and water. Management continues to see a strong M&A pipeline, while emphasizing its ability to create value through operational improvements and portfolio connectivity. Importantly, the acquisition comes as CRH expects continued infrastructure strength and another year of margin expansion. The company reaffirmed its 2026 adjusted EBITDA guidance of $8.1-$8.5 billion and expects its 13th consecutive year of margin expansion.
Overall, the Nordic deal appears strategically aligned with CRH’s connected portfolio model, potentially strengthening its position in infrastructure-driven markets while adding another avenue for long-term growth.
CRH vs. Martin Marietta & Vulcan: Aggregates Race Heats UpCRH, alongside its market peers Martin Marietta Materials, Inc. (MLM - Free Report) and Vulcan Materials Company (VMC - Free Report) , is positioned to benefit from sustained aggregates demand as transportation, water, reindustrialization and other infrastructure projects support construction activity.
Martin Marietta and Vulcan benefit from strong U.S. aggregates positions and infrastructure exposure, but CRH’s broader connected portfolio across aggregates, cementitious materials, roads, water and critical infrastructure gives it more avenues to capture project spending. Its latest Denmark and Finland deal further extends this acquisition-led strategy. CRH appears to have an edge in inorganic growth and portfolio connectivity.
Overall, CRH’s scale, aggressive M&A, geographic diversification and cross-selling opportunities could give it a competitive edge over Martin Marietta and Vulcan as infrastructure investment remains strong.
CRH Stock’s Price Performance & Valuation TrendCRH stock has declined 21.9% over the past three months, underperforming the Zacks Building Products - Miscellaneous industry, the broader Zacks Construction sector and the S&P 500 Index.
Image Source: Zacks Investment Research
CRH stock is currently trading at a discount compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 12.67, as the trend lines suggest below.
Image Source: Zacks Investment Research
Earnings Estimate Trend of CRHOver the past 60 days, CRH’s earnings estimates for 2026 have remained unchanged at $5.90, while those of 2027 have declined to $6.59 per share. The estimates for 2026 and 2027 imply year-over-year improvements of 5.9% and 11.6%, respectively.
Image Source: Zacks Investment Research
CRH currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Společnost AeroVironment v 1. fiskálním čtvrtletí zvýšila tržby o 6 % na 480,5 milionu USD; tržby segmentu autonomních systémů vzrostly o 21 % na 346 milionů USD.
Key Takeaways AVAV delivered $480.5 million in revenues, while Autonomous Systems revenues jumped 21% to $346 million.Record funded backlog of $1.5 billion and $683 million in bookings provide stronger future revenue visibility.New contracts for P550 and Switchblade 600 highlight continued demand for autonomous defense technologies. AeroVironment’s (AVAV - Free Report) fiscal 2027 is off to a strong start, supported by record first-quarter revenues and a funded backlog. The company is seeing particularly strong momentum in its Autonomous Systems (AxS) segment, highlighting the growing importance of unmanned and autonomous capabilities in modern defense operations. AeroVironment generated $480.5 million in first-quarter revenues, up 6% year over year, while AxS revenues increased 21% to $346 million.
The company recorded $683 million in bookings, resulting in a 1.4 book-to-bill ratio. Funded backlog reached a record $1.5 billion, up 37% year over year, providing greater visibility into future revenues.
A key advantage for AeroVironment is its expanding portfolio of autonomous and unmanned defense technologies. The company develops systems spanning autonomous aircraft, precision strike, counter-UAS and directed-energy capabilities, allowing it to address multiple requirements across the modern battlefield. During the fiscal first quarter, the U.S. Army awarded AeroVironment a $117 million contract for its P550 system under the Long-Range Reconnaissance program. The company also received a $51 million Switchblade 600 order supporting the Army’s Lethal Unmanned Systems IDIQ. These awards demonstrate continued demand for AVAV’s autonomous and precision-strike technologies.
The company is also broadening its position across defense technology. Beyond autonomous systems, AeroVironment develops precision-strike, counter-UAS, space, directed-energy and cyber capabilities. This diversified portfolio could help AVAV capture a wider range of defense modernization opportunities as governments prioritize technologies designed for increasingly autonomous and contested battlefields.
Other Defense Stocks Benefiting From Autonomous SystemsAlong with AeroVironment, other companies are also positioned to benefit from growing defense demand for autonomous and unmanned systems, as discussed below:
Red Cat Holdings (RCAT - Free Report) is gaining exposure to the autonomous-drone trend through its defense and national-security drone portfolio. Its acquisition of Apium Swarm Robotics has expanded its capabilities in autonomous swarming technology.
Kratos Defense & Security Solutions (KTOS - Free Report) also offers exposure through its unmanned-systems business, alongside broader defense technologies spanning space, electronics and other mission-critical applications.
AVAV Stock’s Earnings EstimatesThe Zacks Consensus Estimate for fiscal 2027 earnings per share implies a decrease of 1.8% year over year.
Image Source: Zacks Investment Research
AVAV Stock Trades at a DiscountIn terms of valuation, AVAV’s forward 12-month price-to-sales (P/S) is 3X, a discount to the industry’s average of 7.1X.
Image Source: Zacks Investment Research
AVAV Stock’s Price PerformanceIn the past three months, the company’s shares have lost 6.4% compared with the industry’s 16.2% decline.
Akcie společnosti Haemonetics ve čtvrtek vzrostly o více než 13 % poté, co CSL oznámila, že do konce roku 2027 dokončí zavedení zařízení NexSys PCS ve všech svých plazmaferézních centrech v USA.
Haemonetics (NYSE:HAE) shares jumped over 13% to $115.20 on Thursday after CSL set out a timetable for moving its US plasma collection centers onto the company's devices.
CSL Limited (ASX:CSL), the Australian biotechnology company, expects to finish rolling out Haemonetics' NexSys PCS devices with Persona PLUS technology and related disposables by the end of 2027.
Plasma is the liquid portion of blood that donors give at collection centers and manufacturers use to make treatments for rare and chronic diseases.
CSL told Haemonetics it anticipates the transition will cover all of its plasma collection centers currently operating in the US.
The companies signed a non-exclusive supply agreement in August, which allows CSL to use Haemonetics' devices and buy related disposables in the US while keeping other suppliers available.
The scope and timing of the rollout remain subject to change under the terms of the supply agreement, and implementation details have yet to be determined.
Haemonetics is not updating its previously issued financial year 2027 guidance, so its forecast remains unchanged for now.
The company expects to update investors on the agreement's anticipated effect on its financial year 2027 results during its second-quarter earnings call in November 2026.
Disposables are single-use items that are replaced for each donor and generate recurring revenue for device makers beyond the initial equipment sale.
Ultragenyx prodá poukaz FDA k prioritnímu přezkumu vzácných pediatrických onemocnění za 210 mil. USD; po úhradě 42 mil. USD organizaci NIH jí před dalšími náklady zůstane přibližně 168 mil. USD.
Key Takeaways Ultragenyx will receive $210M from selling a Rare Pediatric Disease Priority Review Voucher.The deal adds non-dilutive cash to support research, development and commercialization efforts.About $168M remains before other costs after a $42M NIH payment tied to a prior patent license. Ultragenyx Pharmaceutical (RARE - Free Report) has entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million. The transaction is expected to provide the rare-disease drugmaker with a meaningful influx of non-dilutive cash, strengthening its financial position as it advances therapies for rare and ultra-rare diseases. The proceeds could also support Ultragenyx’s efforts to move toward profitability without requiring an equity financing. The deal remains subject to the satisfaction of certain regulatory and customary closing conditions.
The PRV was awarded to Ultragenyx following the FDA approval of Genglycos (pariglasgene brecaparvovec-opnr), also known as DTX401. Under the agency’s Rare Pediatric Disease PRV program, an eligible sponsor can receive a voucher after gaining approval for a qualifying rare pediatric disease therapy. The voucher can then be redeemed to obtain priority review for a future marketing application for a different eligible product. Importantly, the voucher can also be sold or transferred, allowing drugmakers to monetize the regulatory asset and generate capital.
Recent FDA Approval of Genglycos Earns RARE a Valuable PRVIn August, the FDA granted accelerated approval to Ultragenyx’s Genglycos to treat glycogen storage disease type Ia (GSDIa), making it the first treatment designed to address the underlying cause of the rare metabolic disorder. The therapy is indicated as an adjunct to nutritional management to reduce daily cornstarch intake in adults and pediatric patients aged eight years and older. The approval represents another important regulatory milestone for Ultragenyx as the company expands its portfolio of therapies targeting serious rare diseases.
Year to date, RARE shares have plunged 35.3% against the industry’s 1.3% growth.
Image Source: Zacks Investment Research
Ultragenyx’s Genglycos is an AAV8 gene therapy developed to target the underlying disease biology in GSDIa. By focusing on the root cause rather than solely managing symptoms through dietary measures, the therapy broadens treatment options for patients with a condition associated with significant unmet medical need. The approval marked Ultragenyx’s first gene therapy product and fifth FDA approval overall, strengthening its rare-disease franchise and expanding its presence in genetic and metabolic disorders.
The approval was strategically important because the resulting PRV gives Ultragenyx immediate financial flexibility beyond Genglycos’ commercial opportunity. The $210 million sale will provide non-dilutive capital to support research, development and commercialization. However, 20% ($42 million) of the proceeds is payable to the NIH under a prior patent license agreement, leaving about $168 million before other costs. Ultragenyx has previously benefited from PRV monetization to fund Genglycos’ development, highlighting the program’s role as a source of non-dilutive funding for rare-disease innovation.
Ultragenyx’s marketed portfolio spans several rare metabolic and genetic disorders. Crysvita (burosumab-twza) is approved for X-linked hypophosphatemia in adults and pediatric patients and for tumor-induced osteomalacia, while Mepsevii (vestronidase alfa-vjbk) treats mucopolysaccharidosis type VII. Dojolvi (triheptanoin) is indicated for long-chain fatty acid oxidation disorders, and Evkeeza (evinacumab-dgnb) is approved for homozygous familial hypercholesterolemia. Evkeeza is a partnered drug, with Ultragenyx holding rights to develop, commercialize and distribute it outside the United States, while Regeneron Pharmaceuticals commercializes it in the United States.
In September, the FDA also approved Fayuvi (rebisufligene etisparvovec-hopf), a one-time gene therapy for the neurologic manifestations of mucopolysaccharidosis type IIIA, also known as Sanfilippo syndrome Type A, in pediatric patients with preserved neurodevelopmental function. The approval marked Ultragenyx’s sixth FDA approval overall and second gene therapy approval, further expanding its presence in rare and ultra-rare diseases.
RARE’s Zacks Rank & Stocks to ConsiderUltragenyx currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the biotech sector are Alnylam Pharmaceuticals (ALNY - Free Report) , currently sporting a Zacks Rank #1 (Strong Buy), and CRISPR Therapeutics (CRSP - Free Report) and Aldeyra Therapeutics (ALDX - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, estimates for Alnylam’s 2026 earnings per share have decreased from $8.65 to $8.63. Over the same period, earnings estimates for 2027 have decreased from $12.13 to $12.04. ALNY shares have plunged 43.5% year to date.
Alnylam’s earnings beat estimates in three of the trailing four quarters and missed in the remaining one, with the average surprise being 27.58%.
Over the past 60 days, estimates for CRISPR Therapeutics’ 2026 loss per share have narrowed from $4.53 to $4.47. Over the same period, earnings estimates for 2027 have narrowed from $3.63 to $3.61. CRSP shares have lost 0.1% year to date.
CRISPR Therapeutics’ earnings beat estimates in two of the trailing four quarters and missed on the remaining two occasions, with the average negative surprise being 1.38%.
Over the past 60 days, loss per share estimates for Aldeyra Therapeutics have narrowed from 43 cents to 39 cents for 2026. Over the same period, estimates for 2027 loss per share have narrowed from 22 cents to 16 cents. ALDX shares have plunged 81.5% year to date.
Aldeyra Therapeutics’ earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 29.25%.
Advokátní kancelář Rosen Law Firm prověřuje možné nároky investorů vůči společnosti Azenta v souvislosti s údajně zavádějícími informacemi. Akcie AZTA po zveřejnění rezignace generálního ředitele, k níž došlo 22. srpna 2026, klesly 24. srpna 2026 o 12 %.
New York, New York--(Newsfile Corp. - October 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/azenta-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On August 24, 2026, Azenta filed with the SEC a current report on Form 8-K which stated that on "August 22, 2026, John P. Marotta resigned as President and Chief Executive Officer of Azenta, Inc. (the "Company") and as a member of the Company's Board of Directors (the "Board"), effective as of August 22, 2026 (the "Effective Date")."
On this news, Azenta's stock fell 12% on August 24, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318104
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Helmerich & Payne očekává ve čtvrtém fiskálním čtvrtletí přímé marže u horní hranice výhledu; International Solutions má dosáhnout 45 milionů USD. ExxonMobil během 12 měsíců rozšíří FlexRobotics ze dvou na devět systémů.
Key Takeaways Helmerich & Payne expects fiscal fourth-quarter margins near the high end of its guided range.International Solutions is expected to deliver about $45 million in direct margins for the quarter.ExxonMobil plans seven more FlexRobotics systems, bringing its total deployment to nine. Helmerich & Payne (HP - Free Report) is heading into the end of fiscal 2026 with encouraging operating momentum. The company recently said it expects direct margins across the North America Solutions, International Solutions and Offshore Solutions businesses to come in at or near the high end of their previously issued fiscal fourth-quarter guidance. The update also points to steady activity across its portfolio and a constructive start to fiscal 2027. Separately, HP is expanding its FlexRobotics relationship with ExxonMobil Holdings Corporation (XOM - Free Report) , adding another potential avenue for technology-led growth.
Fiscal Q4 Performance on TrackHelmerich & Payneexpects its North America Solutions average rig count to be near the high end of its fiscal fourth-quarter guided range. This is important because the segment remains the company’s largest operating business and provides a key source of earnings and cash generation.
International Solutions is expected to post an average rig count near the midpoint of its range, while Offshore Solutions is also expected to come in around the midpoint for the average rig count and management contracts.
The margin outlook is particularly notable in International Solutions. Helmerich & Payneexpects the segment to generate direct margins of around $45 million during the quarter, near the upper end of the previously provided $25-$45 million range. Management highlighted the performance as a strong finish to fiscal 2026, even as geopolitical disruptions continue to affect activity in parts of the Middle East.
The company said other financial guidance items provided with its Aug. 5 earnings release remain unchanged. That stability gives investors greater visibility into the expected fiscal fourth-quarter performance rather than suggesting that the improved margin outlook is being driven by a broad revision to the company’s overall assumptions.
Encouraging Fiscal 2027 SetupHP’s comments also extend beyond the fiscal fourth-quarter results. Management expects overall direct margins in fiscal 2027 to be stronger than in fiscal 2026, supported by customer discussions and contracting activity across its global portfolio. In North America, the company sees activity remaining robust and commercial trends continuing to support the business.
Internationally, the outlook is more mixed. HP expects stronger activity in Latin America to partly offset near-term reductions in the Middle East. This geographic diversification remains an important feature of the company’s strategy because stronger performance in one region can help cushion disruptions in another.
Management also reiterated its commitment to reducing leverage to approximately 1x net debt to adjusted EBITDA by calendar year-end 2027 while maintaining the base dividend. The combination of improving margins, sustained activity and a stated balance-sheet objective could support investor confidence in the company’s medium-term financial profile.
FlexRobotics Deployment Adds a Technology CatalystOn the same day, Helmerich & Payne announced that ExxonMobil is expanding its use of FlexRobotics technology. After the initial deployment of two systems on HP rigs, ExxonMobil plans to add seven more systems over the next 12 months. That would bring the total number of FlexRobotics systems operating for ExxonMobil to nine.
This expansion is strategically important because it demonstrates that HP’s automation technology is moving beyond initial deployments and into broader operational use. FlexRobotics is designed to automate repetitive rig-floor activities, which can reduce employee exposure to higher-risk tasks while improving consistency, precision and operating efficiency.
For Helmerich & Payne, a wider deployment with a major customer such as ExxonMobil provides validation of the technology’s commercial value. This can also strengthen the company’s broader automation portfolio and deepen its relationship with an important industry customer. While the announcement does not disclose financial terms, the planned increase from two systems to nine represents a meaningful expansion in scope.
The technology opportunity is particularly relevant as drilling contractors look for ways to improve performance without relying solely on higher rig counts. Automation can help customers extract greater efficiency from existing operations, making technology adoption an additional growth lever alongside traditional drilling activity.
Bottom LineHP’s Oct. 7 update provides investors with two distinct positives. Near term, the company expects fiscal fourth-quarter direct margins to land at or near the upper end of guidance, with North America activity remaining strong and International Solutions delivering an expected $45 million in direct margins. Longer term, management sees stronger overall direct margins in fiscal 2027, supported by customer activity and a more favorable outlook in Latin America.
At the same time, the expanded ExxonMobil FlexRobotics deployment strengthens HP’s position in drilling automation and shows that customers are increasingly adopting its technology. The combination of solid operating execution, international opportunities, automation growth and a focus on balance-sheet improvement gives HP a constructive setup as it enters fiscal 2027.
HP's Zacks Rank & Key PicksCurrently, HP and XOM have a Zacks Rank #3 (Hold) each.
Investors interested in the energy sector might consider some better-ranked stocks, such as Marathon Petroleum (MPC - Free Report) and Delek US Holdings (DK - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Marathon Petroleum is valued at $126.22 billion. The company is a leading U.S. independent refiner, marketer and transporter of petroleum products, with a strong refining footprint and an extensive midstream business. Marathon Petroleum benefits from its integrated operations, strategic refining assets and diversified earnings streams across the energy value chain.
Delek US Holdings is valued at $4.63 billion. It is a diversified downstream energy company engaged in petroleum refining, renewable fuels, asphalt production and logistics operations. Delek US Holdings operates multiple refineries in the United States and is committed to delivering safe, reliable energy while investing in cleaner energy initiatives.
Casey’s v 1. čtvrtletí fiskálního roku 2027 zvýšila zisk na akcii o 27,7 % na 7,37 USD a tržby o 24,3 % na 5 678,3 mil. USD, čímž překonala očekávání trhu.
It has been about a month since the last earnings report for Casey's General Stores (CASY - Free Report) . Shares have added about 0.7% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Casey's due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent catalysts for Casey's General Stores, Inc. before we dive into how investors and analysts have reacted as of late.
CASY Q1 Earnings Beat Estimates on Inside and Fuel GainsCasey’s General Stores posted first-quarter fiscal 2027 earnings of $7.37 per share, which increased 27.7% year over year and surpassed the Zacks Consensus Estimate of $6.60. Revenues rose 24.3% to $5,678.3 million, beating the $5,624 million consensus mark.
Higher inside and fuel gross profit supported the quarter, partly offset by increased operating expenses. Inside same-store sales rose 3.2%, while fuel same-store gallons slipped 0.3%.
CASY's Inside Sales Gain on Prepared Food DemandTotal inside sales increased 5.6% year over year to $1,777.5 million. Prepared food and dispensed beverage same-store sales advanced 4.8%, driven mainly by positive traffic, led by whole pizzas. Grocery and general merchandise same-store sales increased 2.7%, helped by non-alcoholic beverages.
Inside gross profit rose 6.3% to $749.8 million, while inside margin expanded about 30 basis points to 42.2%. Prepared food and dispensed beverage margin improved to 59.3% from 58%, reflecting favorable mix and cost-of-goods management, while grocery and general merchandise margin eased to 35.6% from 35.9%.
Casey's Fuel Profit Climbs on Margin StrengthTotal fuel gallons sold increased 2.5% to 934.2 million gallons as a larger store base more than offset the modest same-store decline. Fuel gross profit climbed 19.6% to $446.9 million.
Fuel margin, excluding credit card fees, widened to 47.8 cents per gallon from 41 cents a year earlier. Management said its fuel capabilities helped the company navigate a volatile environment and produce strong results during the quarter.
CASY's Costs Rise as Store Base ExpandsOperating expenses increased 8% to $754.1 million. Operating 64 more stores than a year earlier accounted for about 2% of the increase, while higher same-store credit card fees added roughly 1.5%.
Same-store employee expense contributed about 1% of the increase, primarily because of higher labor rates, while labor hours were nearly flat. Insurance accounted for another roughly 1% of the increase.
Casey's Earnings Growth Outpaces Expense IncreaseNet income advanced 27.1% year over year to $273.7 million. EBITDA increased 17.1% to $485.1 million as higher inside and fuel gross profit outweighed part of the cost pressure.
Cash provided by operating activities totaled $384.1 million compared with $372.4 million a year ago. Casey’s spent $194.4 million on property and equipment and ended July with about $1.4 billion of available liquidity, including $524.1 million in cash and cash equivalents.
CASY Expands Store Base and Returns CashCasey’s ended the quarter with 2,959 stores, up from 2,944 at the start of the fiscal year. The company added nine newly constructed stores and 12 acquired locations while closing or divesting six stores.
The company repurchased about $45.6 million of shares during the quarter and had approximately $973 million remaining under its authorization. The board also approved a quarterly dividend of 65 cents per share, payable on Nov. 13, 2026.
Casey's Keeps Fiscal 2027 Outlook UnchangedFor fiscal 2027, Casey’s continues to expect inside same-store sales growth of 2%-5%, with inside margin above 42%. Same-store fuel gallons are projected to range from down 1% to up 1%, while operating expenses are expected to increase 5%-7%.
The company continues to target EBITDA growth of 8%-10% and plans to open at least 120 stores through acquisitions and new construction. Casey’s also expects about $800 million of capital spending and roughly $95 million of net interest expense.
CASY's Three-Year Plan Adds a Longer Growth RunwayCasey’s new three-year plan calls for at least 400 additional stores during fiscal 2027 through fiscal 2029 through a mix of new builds and acquisitions. The investor plan also targets roughly $2 billion of free cash flow over the period and continued inside-store margin expansion.
The strategy pairs unit growth with operating-efficiency initiatives intended to keep operating-expense growth below EBITDA growth. Identified workstreams include store simplification, supply-chain efficiency, kitchen optimization, centralized procurement and a scalable support model as the store network expands.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.
VGM ScoresAt this time, Casey's has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a score of C on the value side, putting it in the middle 20% for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Casey's has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Elastic představila AlertZero, tým agentů AI pro bezpečnostní operace, který automatizuje třídění výstrah, vyšetřování a lov hrozeb. Produkt bude dostupný v technické preview verzi.
Elastic Announces AlertZero, a Team of Specialized AI Agents for the Security Operations Lifecycle Elastic (NYSE: ESTC) today introduced AlertZero, the agentic layer built into Elastic Security, with a team of specialized agents that learn from and adapt to how a security team already works. The agents handle alert triage, investigation, threat hunting, detection tuning and forensic analysis, so each alert gets an evidence-backed answer. This puts analysts on the path to an equivalent of inbox zero: a short queue of recommended actions instead of thousands of raw alerts. Analysts retain full control over which actions are automated and which require human judgement: they choose how much work to delegate to AlertZero and when they need to make the decisions. Releasing into Technical Preview, AlertZero works with any model in any deployment, so teams can adopt AI on their terms.
Security teams face the same persistent bottleneck: alert volume has outpaced the analysts available to work through it, and false positives add to a queue that was already too large to clear. As attackers' use of AI evolves, new problems keep compounding this issue. In a recent high-profile attack, an autonomous AI agent generated more than 17,000 events across a production environment in only four days, moving from a dataset-pipeline exploit to credential theft and lateral movement. The individual signals were detectable, but understanding the attack required connecting them.
That is exactly what AlertZero was built for. It continuously correlates and investigates activity while helping teams reduce false positives that clog the alert queue, with the flexibility to adapt as threats evolve.
AlertZero organizes that work around Watches: specialized named groups of agents with defined responsibilities that run on triggers and schedules. Each Watch focuses on a specific area of security operations and carries its findings into a shared investigation record:
Triage Watch pares down the alert queue through enrichment, decides true or false, closes the noise with a reason, and escalates the real alerts.Hunt Watch handles the legwork by continuously threat hunting, driven by what runs in it and what the threat research says.Detection Watch learns from the other Watches: proposes tuning for noisy rules and new rules for gaps. It will not change a rule without approval.Forensics Watch provides specialist depth for forensics, malware analysis, and exploit paths when work requires skills a typical SOC may not have on staff.Security investigations rarely stay inside one data source or one model. Analysts may need to change models as an investigation develops, based on the task and the evidence they are working with — a flexibility many AI security tools can't offer. AlertZero is designed to provide that flexibility. It runs on Elastic's full data foundation, including structured and unstructured data, logs, and metrics, and works with whatever model an organization chooses across Elastic Cloud, self-managed, or air-gapped deployments.
"What makes AlertZero different is that our team who built it have sat in the SOC analyst's seat,” said Mike Nichols, general manager, Security, Elastic. "We focused on building a platform that gives teams enough visibility and control to deploy agentic automation at the scale and scope they can handle effectively. Every Watch in AlertZero aligns directly with key SOC responsibilities, and the level of autonomy is customizable for each Watch. Security teams get help where they need it most, with the model and deployment that are most effective for their needs.”
Customers can extend AlertZero using the same Agent Builder skills and Elastic Workflows that Elastic used to build it, adding workflows specific to their environment without leaving the platform.
Availability
AlertZero will be available to Elastic Security customers as a Technical Preview in Elastic Cloud, self-managed, and air-gapped environments. It builds on existing Elastic Security capabilities, including Attack Discovery, ES|QL, Agent Builder, and Elastic Workflows.
Receive updates on AlertZero by signing up here.
Additional Materials
Blog: Inside what's coming with AlertZero: connecting investigation, hunting, and response
About Elastic
Elastic (NYSE: ESTC) integrates its deep expertise in search technology with artificial intelligence to help everyone transform all of their data into answers, actions, and outcomes. Elasticsearch, which is the foundation for its search, observability, and security solutions, is used by thousands of companies, including more than 75% of the Fortune 100. Learn more at elastic.co.
Elastic and associated marks are trademarks or registered trademarks of elasticsearch B.V. and its subsidiaries. All other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261008390511/en/
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Elastic spustil soukromý náhled AI agenta nightshift AI SRE, který v platformě Elastic Observability průběžně odhaluje a analyzuje incidenty napříč technologickým stackem.
The AI SRE uses complete context from across the entire stack to continuously detect issues and learn from every incident, delivering evidence-backed answers engineers can trust
SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC) today announced the private preview of Elastic® nightshift AI SRE, an AI agent built into Elastic Observability that investigates like an engineer and shows its work. It continuously detects and investigates issues across the entire stack with full context, including surfacing unknowns that rule-based alerts miss. Elastic nightshift AI SRE tests multiple root-cause hypotheses in parallel against telemetry and other relevant context to deliver evidence-backed answers with its reasoning visible at every step.
Cloud-native systems now produce more telemetry than any team can review manually, and agentic development has made the problem worse: code that writes code can fail in ways that don't trip a clean error code or fire an alert. In the past year, 78% of organizations had at least one incident where no alert fired and customers found the problem first, according to a NeuBird AI study from April 2026. Once an incident surfaces, investigation depends on context that is usually incomplete: telemetry dropped to control cost, knowledge scattered across code, runbooks and Slack, and lessons from past incidents lost. Observability agents only see what alerts catch, while standalone AI SREs reason over data they don't own. Elastic nightshift AI SRE brings detection, investigation, context and remediation together in a single AI SRE built into Elastic Observability.
Transparent Investigation
Elastic nightshift AI SRE investigates like an SRE would: ruling out dead ends, following connected signals and converging on root cause with transparent reasoning. Once an investigation identifies the likely root cause, Elastic nightshift AI SRE recommends a fix. It can select an existing workflow or pre-configured action and fill in the incident parameters or provide commands for an engineer to run. Engineers can inspect the investigation steps, including the queries the agent ran and the underlying data.
Complete Context
Each investigation draws on full context based on cost-efficient telemetry storage, so customers can keep what the AI needs instead of sampling it away. A knowledge graph connects that telemetry to source code from GitHub repositories, so Elastic nightshift AI SRE can point to the commit that likely caused an exception instead of leaving engineers to guess what changed. Investigation memory compounds over time, so every resolved incident makes the next investigation faster to resolve.
Detects Unknowns
Elastic nightshift AI SRE does not wait for a rule to fire. It continuously evaluates the environment and all telemetry for what needs attention, correlating alerts, SLOs and anomalies into findings an engineer should actually see, including issues that preconfigured alerts are blind to.
“Named role agents, including AI SRE, are the first step to AI-fueled operations,” said Shannon Kalvar, IDC Senior Research Director. “These agents need access to a broader context, particularly heterogeneous estates, along with the ability to both learn from their own action and reflect on those actions after the fact to begin to create the human-directed operating model of the future.”
"Most Observability agents only get smarter by scraping more data. Elastic nightshift AI SRE gets smarter by paying attention to how engineers work through investigations, and by checking its own homework once an incident is closed," said Baha Azarmi, general manager, Observability, Elastic. "That is how it keeps up with production without running up a token bill nobody wants to see."
Availability
Elastic nightshift AI SRE is available today in private preview on Elastic Observability Serverless, free for existing Elastic customers during the early access period. Elastic plans to bring it to technical preview later this year with broader support for third-party tools and data stores. Teams can join the waitlist at: elastic.co/observability/ai-sre/signup
Additional Materials
Read the blog: Meet Elastic nightshift AI SRE, your always-on coworker Learn more at: elastic.co/observability/ai-sre Sign up to request early access: elastic.co/observability/ai-sre/signup About Elastic
Elastic (NYSE: ESTC) integrates its deep expertise in search technology with artificial intelligence to help everyone transform all of their data into answers, actions, and outcomes. Elasticsearch, which is the foundation for its search, observability, and security solutions, is used by thousands of companies, including more than 75% of the Fortune 100. Learn more at elastic.co.
Elastic and associated marks are trademarks or registered trademarks of elasticsearch B.V. and its subsidiaries. All other company and product names may be trademarks of their respective owners.
ABM Industries ve třetím fiskálním čtvrtletí zvýšila upravený zisk na akcii o 27 % na 1,04 USD a tržby o 4,2 % na 2,32 miliardy USD; zároveň zvýšila celoroční výhled zisku.
A month has gone by since the last earnings report for ABM Industries (ABM - Free Report) . Shares have lost about 2% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is ABM Industries due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
ABM posted adjusted earnings of $1.04 per share, which increased 27% year over year and surpassed the Zacks Consensus Estimate of $1.01 by 3%. Higher segment operating profit, lower tax expense and reduced ongoing corporate costs supported the bottom line.
Revenues rose 4.2% to $2.32 billion and beat the consensus mark of $2.30 billion by 0.7%. Growth was led by M&D and Aviation. Semiconductor, microgrid and data center-related revenues reached nearly $775 million through nine months, rising 26% organically.
ABM Revenue Growth Led by M&D and AviationM&D revenues climbed 17.6% year over year to $481 million, including 7.8% organic growth and 9.9% growth from acquisitions. The increase reflected client expansions and the WGNSTAR acquisition. Aviation revenues rose 12.5% to $328.1 million, supported by healthy travel demand and the continued ramp of the Heathrow Airport contract.
Business & Industry revenues declined 2.6% to $1.01 billion, reflecting the exit of a large U.K.-based client and West Coast softness. Education revenues were nearly flat, up 0.3% to $235.8 million.
ABM Industries Manages Technical Solutions Project TimingTechnical Solutions revenues increased 4.2% to $259.9 million, with organic growth of 2.1% and acquisitions adding another 2.1%. Strong HVAC and battery energy storage system activity was partly offset by microgrid project delays tied to an important client.
The segment generated operating profit of $21.5 million, up 10.8%, while margin improved to 8.3% from 7.8% on favorable service mix. Management said about $15 million of projects were deferred in the quarter, with nearly all expected to land in the fourth quarter and a small portion in the first quarter of fiscal 2027.
ABM Expands High-Growth Technology ExposureSemiconductor revenues reached about $300 million through the first nine months of fiscal 2026 and grew 65% organically. Microgrid revenues were about $300 million, up 17% organically, while data center revenues totaled roughly $175 million and advanced 8% organically. Together, these markets represented more than 11% of company revenues and carried double-digit blended operating margins.
Management said WGNSTAR is tracking well above its earlier $120-$130 million annualized revenue expectation. ABM reported two or three cross-sells across the combined semiconductor client base. The data center pipeline is also a multiple of its year-ago level, while a roughly $20 million Army Corps of Engineers microgrid project is expected to be executed in 2027.
ABM Industries Shows Better Margin ExecutionOn a GAAP basis, net income increased 18.9% to $49.7 million, or 84 cents per share, from $41.8 million, or 67 cents. Selling, general and administrative expenses declined 3.5% to $171.3 million. Adjusted EBITDA increased 11% to $139.6 million.
Segment operating margin was 7.7%, flat year over year but up 40 basis points sequentially. Business & Industry margin expanded to 7.4% from 7.1% and Education margin improved to 9.7% from 9%.
Aviation margin fell to 5.6% from 6.8% as airline customers sought cost relief amid higher jet fuel costs. M&D margin declined to 8.4% from 8.9%, reflecting growth investments and nearly $4 million of incremental WGNSTAR amortization. Excluding that amortization, the segment margin was 9.2%.
ABM Strengthens Cash Flow and LeverageThird-quarter operating cash flow was $146.8 million and free cash flow was $128.4 million. Through nine months, operating cash flow increased to $275 million from $101 million, while free cash flow rose to $199.6 million from $42.4 million, supported by working-capital management and ERP stabilization.
Total indebtedness ended the quarter at $1.8 billion, while leverage improved to 2.9X from 3.2X in the previous quarter. Available liquidity was $605.8 million, including $110.5 million of cash and equivalents. ABM also established a $300 million accounts receivable financing facility.
ABM Industries Raises Fiscal 2026 OutlookABM raised its adjusted earnings outlook to $3.95-$4.10 per share from $3.85-$4.15, increasing the midpoint.
Organic revenue growth is still expected toward the high end of 3-4%, with total revenue growth toward the high end of 4-5%. Segment operating margin is now projected to be in the band of 7.7-7.8% compared with the prior 7.8-8% range.
The company lifted its full-year operating cash flow expectation to about $300 million and free cash flow to about $210 million, up $25 million from the prior free cash flow outlook. Interest expense is still expected to be $110 million and the normalized tax rate remains at 29-30%.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a flat trend in fresh estimates.
VGM ScoresAt this time, ABM Industries has a nice Growth Score of B, though it is lagging a bit on the Momentum Score front with a C. However, the stock has a score of A on the value side, putting it in the top quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook ABM Industries has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Key Takeaways MP Materials more than doubled NdPr production in 2025, reaching a record 2,599 MT.MP expects Q3 2026 NdPr output to exceed 1,000 MT as throughput and plant reliability improve.MP is expanding magnet capacity, with commercial shipments expected to begin in Q4 2026. MP Materials (MP - Free Report) is accelerating efforts to strengthen its position across the U.S. rare earth supply chain, with rising NdPr production, expanding heavy rare earth capabilities and growing downstream magnet manufacturing. The company’s recent operational milestones highlight its progress toward building a fully integrated, end-to-end rare earth platform in the United States.
In 2025, the company’s Mountain Pass operations delivered a record 2,599 metric tons (MT) of neodymium-praseodymium (NdPr), more than double the 1,294 MT produced in 2024. The increase reflected continued process optimization and production ramp-up efforts.
In the first quarter of 2026, the company produced a record 917 MT of NdPr, up 63% year over year. Production increased 41% year over year to 840 metric tons in the second quarter of 2026 despite a scheduled semiannual maintenance outage at Mountain Pass. Management expects third-quarter 2026 NdPr production to have exceeded 1,000 metric tons as throughput and plant reliability improved.
MP remains on track to begin producing terbium and dysprosium later this year, with first samarium production targeted for 2028. The company recently entered into a multiyear agreement to supply gadolinium oxide to a leading U.S. aerospace and defense manufacturer.
MP Materials continues to expand its downstream manufacturing footprint as well. In December 2025, the company successfully produced its first neodymium-iron-boron (NdFeB) permanent magnets on a commercial scale at its Independence facility located in Fort Worth, TX.
The company has been delivering magnetic precursor products to General Motors Company (GM - Free Report) under a supply agreement since the first quarter of 2025, generating revenues for its Magnetics segment. During the second quarter of 2026, MP Materials delivered magnets to General Motors for in-vehicle qualification testing and expects to begin commercial shipments in the fourth quarter of 2026, followed by a steady production ramp.
As of June 30, 2026, MP had collected $150 million in required GM prepayments and delivered $104.5 million of precursor products. The remaining $45.5 million is expected to be delivered within a year. Once that is completed, MP expects to shift to sales of finished magnets instead of additional precursor sales to GM.
MP is expanding operations at its Independence facility and has begun construction of the 10X magnetics facility. Commissioning activities for scaled heavy rare earth separation are also expected to begin soon at Mountain Pass. 10X will significantly expand MP’s fully integrated U.S. rare-earth magnetics manufacturing platform, which already encompasses mining and refining, metallization and alloying, sintering, finished magnet production and closed-loop recycling. Once operational, the new campus is expected to contribute to the company’s total production capacity of approximately 10,000 metric tons of NdFeB rare-earth magnets per year, advancing the nation’s ability to produce these strategic components domestically.
MP Materials has also worked with U.S. and allied drone manufacturers to launch Project Swarm, an industrial coordination initiative designed to aggregate and standardize future magnet demand. It has already signed subscription agreements with several participants. The company’s partnership with Apple (AAPL - Free Report) on magnet recycling, magnet production and joint development also continues to advance.
MP’s Price Performance, Valuation & EstimatesMP Materials shares have fallen 34.4% in the past year, underperforming the industry’s 20.1% growth.
Image Source: Zacks Investment Research
MP is trading at a forward 12-month price/sales multiple of 11.94X, a significant premium to the industry’s 1.65X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MP Materials’ 2026 earnings stands at 5 cents per share against a loss of 24 cents in 2025. The 2027 earnings estimate is currently pegged at 81 cents per share, implying growth of 1,523%.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MP Materials for both 2026 and 2027 have moved down, as shown below.
Image Source: Zacks Investment Research
The company currently carries a Zacks Rank #5 (Strong Sell).
Společnost Howmet ve 2. čtvrtletí 2026 zvýšila upravenou EBITDA o 39 % na 817 milionů USD a marži na 32,1 %. Výhled tržeb pro rok 2026 zvedla na 10–10,1 miliardy USD.
Key Takeaways Howmet's Q2 2026 adjusted EBITDA jumped 39% to $817 million, with margin expanding 340 bps to 32.1%.Strong aerospace and gas turbine demand fueled 24% revenue growth, while productivity gains lifted margins.Howmet raised its 2026 revenue outlook to $10-$10.1 billion and expects adjusted EBITDA margin of 32.1-32.2%. Howmet Aerospace Inc. (HWM - Free Report) achieved a solid adjusted EBITDA of $817 million in the second quarter of 2026, which surged 39% year over year. The company's adjusted EBITDA margin reached 32.1%, reflecting an increase of 340 basis points (bps). The adjusted operating margin also improved 350 bps to 28.8%.
Despite the rise in operating expenses, the improved margin performance reflects the benefits of strong top-line growth, operational leverage and productivity gains. It’s worth noting that Howmet reported revenues of $2.55 billion in second-quarter 2026, which increased 24% year over year. The revenues were driven by persistent strength across commercial aerospace, defense aerospace and gas turbine markets.
Solid demand across end markets, robust backlog level and expected synergies from the Consolidated Aerospace Manufacturing (CAM) buyout are expected to drive its top-line and margin performance. For 2026, Howmet raised its revenue outlook from $9.575-$9.725 billion to $10.00-$10.10 billion.
For the year, HWM expects adjusted EBITDA of $3.21-$3.25 billion, with margin projected in the range of 32.1-32.2%. The projected adjusted EBITDA margin indicates a year-over-year expansion of 280 bps at the midpoint. Also, for the third quarter of 2026, adjusted EBITDA is expected in the range of $825-$835 million, with a margin of 32.2-32.3%.
Peer’s Margin PerformanceTextron Inc.’s (TXT - Free Report) cost of sales rose 4.2% year over year to $3.09 billion in second-quarter 2026. Textron’s gross profit margin declined 100 bps to 17.8% in the quarter. The decline in Textron’s margin was due to reduced margin in the Bell segment.
RTX Corporation’s (RTX - Free Report) total costs and expenses increased 12.8% year over year to $22 billion in second-quarter 2026. Despite the rise in costs, RTX Corp.’s adjusted operating profit margin expanded 150 basis points (bps) to 11.4% in the quarter. RTX is benefiting from rising aerospace deliveries, growing aftermarket revenues and declining geared turbofan (GTF) engine-related cash costs.
HWM's Price Performance, Valuation and Estimates
Image Source: Zacks Investment Research
Shares of Howmet have gained 18% in the past year against the industry’s decline of 20.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, HWM is trading at a forward price-to-earnings ratio of 36.29X, above the industry’s average of 27.69X. Howmet carries a Value Score of D.
Očekává se, že Simmons First National ve čtvrtletí dosáhne zisku 0,53 USD na akcii, což představuje meziroční nárůst o 15,2 %, při tržbách 255,21 milionu USD.
The market expects Simmons First National (SFNC - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 15. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis bank holding company is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of +15.2%.
Revenues are expected to be $255.21 million, up 10% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.45% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Simmons First National?For Simmons First National, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.50%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Simmons First National will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Simmons First National would post earnings of $0.53 per share when it actually produced earnings of $0.50, delivering a surprise of -5.66%.
Over the last four quarters, the company has beaten consensus EPS estimates just once.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Simmons First National appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAmong the stocks in the Zacks Banks - Southeast industry, Home BancShares (HOMB - Free Report) , is soon expected to post earnings of $0.64 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +4.9%. This quarter's revenue is expected to be $293 million, up 5.5% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Home BancShares has been revised 0.1% up to the current level. Nevertheless, the company now has an Earnings ESP of +0.79%, reflecting a higher Most Accurate Estimate.
When combined with a Zacks Rank of #2 (Buy), this Earnings ESP indicates that Home BancShares will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Advokátní kancelář Rosen Law Firm vyšetřuje možné nároky akcionářů společnosti Cooper Companies v souvislosti s údajně zavádějícími informacemi. Akcie 10. září 2026 klesly o 14,6 % po slabém výhledu a rozhodnutí neprodat divizi CooperSurgical.
New York, New York--(Newsfile Corp. - October 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that CooperCompanies may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased CooperCompanies securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/the-cooper-companies-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
WHAT IS THIS ABOUT: On September 10, 2026, The Motley Fool published an article entitled "Why is Cooper Companies Stock Down 15% Today?". The article stated that Cooper Companies stock fell "after the company's earnings report disappointed Wall Street with weak guidance and a decision to not sell Cooper Surgical."
On this news, Cooper Companies' stock fell 14.6% on September 10, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/318098
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
C.H. Robinson se dohodla na akvizici logistické společnosti RXO za přibližně 5,8 miliardy USD; očekává rozšíření logistické sítě a asi 300 milionů USD nákladových synergií.
Vann Equity Management LLC acquired a new position in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,329 shares of the transportation company’s stock, valued at approximately $641,000.
Several other hedge funds also recently made changes to their positions in the business. Alkeme Wealth LLC acquired a new position in shares of C.H. Robinson Worldwide in the 3rd quarter valued at $1,473,000. Chickasaw Capital Management LLC purchased a new position in C.H. Robinson Worldwide in the third quarter valued at about $2,113,000. Veery Capital LLC bought a new position in C.H. Robinson Worldwide during the third quarter valued at approximately $271,000. Winebrenner Capital Management LLC bought a new position in shares of C.H. Robinson Worldwide in the 3rd quarter valued at approximately $165,000. Finally, Applied Capital LLC FL bought a new stake in shares of C.H. Robinson Worldwide during the 3rd quarter worth $2,693,000. Institutional investors and hedge funds own 93.15% of the company’s stock.
C.H. Robinson Worldwide News Roundup Here are the key news stories impacting C.H. Robinson Worldwide this week:
Positive Sentiment: RXO acquisition could strengthen the business: C.H. Robinson agreed to acquire logistics company RXO for approximately $5.8 billion. The transaction is expected to expand CHRW’s logistics network, improve its technology and artificial-intelligence capabilities, and generate roughly $300 million in cost synergies. CH Robinson to Buy Logistics Firm RXO in $5.8 Billion Deal Positive Sentiment: Potential earnings beat: Zacks said CHRW has a strong history of exceeding analyst estimates and currently has the key factors that could support another quarterly earnings surprise. A beat could help restore investor confidence following the recent weakness in the shares. Will C.H. Robinson Beat Estimates Again? Positive Sentiment: Analyst valuation remains favorable: Brokerages reportedly have a consensus price target of $196.64, substantially above the recent trading level, suggesting analysts see meaningful longer-term upside. C.H. Robinson Consensus Price Target Neutral Sentiment: Industry consolidation is accelerating: CEO Dave Bozeman expects additional freight-broker consolidation as higher diesel costs pressure smaller operators. This could create acquisition opportunities for CHRW but also reflects challenging conditions across the transportation market. C.H. Robinson CEO Sees Freight Broker Consolidation Negative Sentiment: Investors remain concerned about the RXO transaction: Commentary questioning whether the acquisition is a shortcut to value highlights risks from the $5.8 billion price, execution challenges, financing and the time required to realize synergies. Those concerns have contributed to recent weakness in CHRW shares. C.H. Robinson: RXO Is No Shortcut To Value C.H. Robinson Worldwide Stock Performance CHRW stock opened at $135.18 on Thursday. C.H. Robinson Worldwide, Inc. has a 1-year low of $123.64 and a 1-year high of $210.33. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.04. The firm has a market cap of $15.80 billion, a PE ratio of 25.80, a P/E/G ratio of 1.13 and a beta of 0.94. The business’s 50-day moving average price is $148.44 and its two-hundred day moving average price is $169.17. C.H. Robinson Worldwide (NASDAQ:CHRW – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The transportation company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.08. The business had revenue of $4.93 billion during the quarter, compared to analyst estimates of $4.35 billion. C.H. Robinson Worldwide had a return on equity of 38.36% and a net margin of 3.73%.C.H. Robinson Worldwide’s quarterly revenue was up 19.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.29 EPS. As a group, research analysts forecast that C.H. Robinson Worldwide, Inc. will post 6.2 earnings per share for the current year.
C.H. Robinson Worldwide Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Friday, October 2nd. Investors of record on Friday, September 4th were issued a dividend of $0.63 per share. The ex-dividend date was Friday, September 4th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.9%. C.H. Robinson Worldwide’s dividend payout ratio (DPR) is presently 48.09%.
Wall Street Analysts Forecast Growth A number of equities analysts recently issued reports on the stock. Evercore set a $217.00 target price on shares of C.H. Robinson Worldwide in a research report on Tuesday. Janney Montgomery Scott set a $155.00 target price on shares of C.H. Robinson Worldwide in a research note on Tuesday, July 28th. UBS Group restated a “buy” rating on shares of C.H. Robinson Worldwide in a research report on Tuesday. Robert W. Baird lowered their price objective on shares of C.H. Robinson Worldwide from $230.00 to $200.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. Finally, Truist Financial lowered their target price on C.H. Robinson Worldwide from $215.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $195.40.
Get Our Latest Research Report on C.H. Robinson Worldwide
(Free Report)
C.H. Robinson Worldwide, Inc is a global third-party logistics provider that connects shippers with transportation carriers and other supply-chain service providers. The company helps businesses plan, manage and execute the movement of freight across domestic and international markets.
Its services include truckload and less-than-truckload freight brokerage, intermodal transportation, ocean and air freight forwarding, customs services, and transportation management. C.H. Robinson also provides technology and data-driven tools designed to improve shipment planning, visibility, routing and logistics performance.
Founded in 1905 and headquartered in Eden Prairie, Minnesota, C.H.
Featured Stories Five stocks we like better than C.H. Robinson Worldwide Skydance Just Became a Media Giant—With an $80 Billion Debt Load Could Velo3D Be the Next Defense Buyout Target? Penguin Solutions Is Soaring as AI Memory Demand Explodes Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up Want to see what other hedge funds are holding CHRW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW – Free Report).
Receive News & Ratings for C.H. Robinson Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C.H. Robinson Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.
Archer Aviation (ACHR) za poslední tři měsíce klesla o 3,5 %, tedy méně než letecko-vesmírný a obranný sektor, který oslabil o 14,8 %. Poměr ceny k tržbám (P/S) ve výši 30,89 však výrazně převyšuje průměr odvětví 2,07.
Key Takeaways Archer Aviation outperformed its industry over three months despite a 3.5% share-price decline.Archer is advancing eVTOL commercialization through acquisitions, infrastructure and Midnight flight tests.Archer's strong liquidity supports growth, but its premium valuation may limit near-term upside. Archer Aviation Inc. (ACHR - Free Report) shares have lost 3.5% in the past three months, outperforming the Zacks Aerospace-Defense industry’s decline of 14.8% as well as the broader Zacks Aerospace sector’s loss of 16%. However, it underperformed the S&P 500’s return of 3.7% in the same time frame.
Image Source: Zacks Investment Research
Other industry players, such as Virgin Galactic (SPCE - Free Report) and Embraer (EMBJ - Free Report) , have delivered a similar performance in the past three months. Shares of SPCE and EMBJ have gained 16.2% and 18.9%, respectively, in the said period.
ACHR’s stronger performance compared with the broader aerospace and defense industry, along with gains among key peers, could make the stock appealing to investors. However, investors should assess whether ACHR’s solid fundamentals and growth prospects can sustain long-term gains. Evaluating its growth drivers, earnings outlook and key risks will be crucial in determining the stock’s potential for further upside.
Tailwinds for ACHRArcher Aviation continues to advance its position in the eVTOL market through strategic acquisitions, infrastructure development and successful flight demonstrations aimed at accelerating the commercialization of electric air taxis.
In September 2026, Archer Aviation announced the expiration of the Hart-Scott-Rodino waiting period for its planned acquisition of Boeing’s Wisk Aero, SkyGrid and Insitu subsidiaries. The transaction is expected to close by the end of 2026, subject to remaining regulatory approvals and other customary conditions.
Archer Aviation is also building the infrastructure needed for commercial eVTOL operations. The America’s Consortium for Electric Skyways (ACES), launched by Archer Aviation, BETA Technologies and Macquarie Capital, plans to expand interoperable charging infrastructure across Texas and support up to 250 air taxi sites across major airports and metropolitan areas over the next decade.
Meanwhile, Midnight continues to demonstrate progress toward commercial readiness. In September 2026, the aircraft completed a roughly 40-mile roundtrip flight between Salinas and Hollister, CA, in about 12 minutes each way, reaching speeds of 125 mph. These developments could strengthen Archer Aviation’s commercialization outlook as regulatory support, infrastructure and flight testing continue to advance.
Estimates for ACHR’s 2026 Sales and EarningsThe Zacks Consensus Estimate for ACHR’s 2026 sales implies year-over-year growth of 5467.7%. The consensus estimate for its 2026 losses indicates a year-over-year decline.
Image Source: Zacks Investment Research
The stock’s annual bottom-line estimates have moved north over the past 60 days.
Image Source: Zacks Investment Research
ACHR’s ValuationIn terms of valuation, ACHR’s forward 12-month price-to-sales (P/S) is 30.89X, a premium to the industry average of 2.07X. This suggests that investors will be paying a higher price than the company's expected sales growth compared with its industry average.
Image Source: Zacks Investment Research
Virgin Galactic and Embraer are trading at a discount in comparison with ACHR. SPCE’s forward 12-month price-to-sales is 2.09X, while EMBJ’s forward 12-month price-to-sales is 1.47X.
Liquidity Position of ACHRACHR has a current ratio of 10.21. The ratio, being more than one, indicates that ACHR possesses sufficient capital to pay off its short-term debt obligations.
Its industry peers, Virgin Galactic and Embraer, also maintain current ratios above one. SPCE has a current ratio of 1.62, while EMBJ also holds 1.44.
What Should an Investor Do?ACHR’s demand and healthy liquidity position provide a solid foundation for long-term growth. However, the stock’s premium valuation relative to the industry and key peers may limit its near-term upside potential.
Considering these strengths alongside valuation concerns, existing shareholders may consider holding the stock, while prospective investors could wait for a more attractive entry point. Tracking ACHR’s earnings growth, valuation and execution will remain important when evaluating a new investment.
ACHR currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Arm shares have surged nearly 177% this year, every major AI platform runs its chips, and customer demand for its flagship CPU just blew past management's own projections. So why does one closely watched model signal caution?
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The 24/7 Wall St. price target for Arm Holdings (NASDAQ:ARM | ARM Price Prediction) is $284.70. That sits 5.9% below the current price of $302.56, and our model sets that target with high confidence.
24/7 Wall St. Price Target Summary Metric Value Current Price $302.56 Price Target from 24/7 Wall St. $284.70 Upside/Downside -5.9% Model Signal HOLD Confidence Level 90% Arm trades above both our target and the $290.70 consensus. Customer demand for the Arm AGI CPU now exceeds $2 billion, well ahead of the $1 billion opportunity management outlined.
The investment case depends on that gap between stretched near-term valuation and a long-term opportunity that keeps expanding.
Why We Could Be Wrong Our target sits below current trading levels. Real value could come from AGI CPU revenue growing faster than modeled, or from a CPU market that external estimates put as high as $200 billion and $220 billion. The bull case below explains how Arm could beat our model.
Data Center Wins Power Arm’s Massive 2026 Rally Arm is up 176.79% year to date and 20.02% over the past month. Shares sit about 33% below the 52-week high of $452.70.
Fiscal Q1 2027 revenue of $1.289 billion rose 22.4% and beat the $1.267 billion consensus. Data center royalty revenue more than doubled. Non-GAAP EPS of 45 cents came in above guidance. For fiscal Q2, Arm guided to revenue of $1.38 billion, plus or minus $50 million.
Agentic AI Could Carry Arm Toward $428 The bull case of $428.53 assumes Arm becomes the default CPU for AI infrastructure. Neoverse shipments have passed 1.5 billion cores, with the latest 500 million taking nine months versus six years for the first billion.
NVIDIA (NASDAQ:NVDA) Vera, Google Axion, AWS Graviton5, and Microsoft Cobalt 200 all run on Arm. Meta leads the AGI CPU roadmap. CEO Rene Haas said, “Demand is greater than what we shared 90 days ago.” Analysts lean bullish with 8 Strong Buy and 21 Buy ratings.
Margin Dilution and a Rich Multiple Leave Little Room for Error The bear case of $226.30 reflects how much optimism is priced in. GAAP operating margin fell to 7% from 11%, and stock-based compensation reached $343 million. Initial AGI CPU gross margins should land in the high 30% range, maybe low 40s.
Smartphone demand has pulled full-year royalty growth toward the high teens. The Qualcomm (NASDAQ:QCOM) licensing trial is expected in Q4 2026.
Non-GAAP operating margin rose 200 basis points to about 41%. Much spending goes into the AGI CPU family, and trailing 12-month free cash flow reached $1.4 billion.
Arm Trades at a Steep Premium to NVIDIA and Qualcomm NVIDIA builds its Vera CPU on Arm and trades at 25x forward earnings while growing revenue 105.9%, offering faster growth at a lower multiple.
Qualcomm is an Arm licensee entering data center with the Arm-based Dragonfly C1000, trading at 20x forward earnings as revenue slipped 4%.
Company Forward P/E Quarterly Revenue Growth (YoY) Arm 152x 22.4% NVIDIA 25x 105.9% Qualcomm 20x -4% The 24/7 Wall St. price target looks reasonable next to these peers, still meaning a large premium to both.
Arm Price Prediction 2026-2030 Our model sets Arm’s 24/7 Wall St. price target at $284.70 with 90% confidence.
I’d turn constructive if Q3 shows AGI CPU demand converting to revenue with margins moving toward the 50% target. I’d stay cautious if smartphone royalties weaken or supply limits delay shipments.
Year Price Target from 24/7 Wall St. 2026 $284.70 2027 $293.81 2028 $271.52 2029 $275.85 2030 $299.31 Contact [email protected] for any questions or corrections.
Shake Shack vstoupí do Brazílie ve spolupráci s partnerem Bold Hospitality: do roku 2036 plánuje otevřít 40 restaurací, přičemž první v São Paulu otevře v roce 2027.
Key Takeaways Shake Shack plans 40 Brazil locations by 2036, with its first Sao Paulo restaurant set to open in 2027.The Bold Hospitality partnership leverages local expertise and suppliers to support SHAK's Brazil entry.SHAK's Q2 licensing revenues rose 7.1% to $14.2M, supporting its goal of 40-45 licensed openings in 2026. Shake Shack Inc. (SHAK - Free Report) is expanding its footprint in Latin America through a new licensing partnership with Bold Hospitality Company to enter Brazil. The move marks another milestone in the company's international growth strategy, following seven years of operations in Mexico and its planned expansion into Panama.
Brazil has been among Shake Shack's most requested international markets. The planned entry is expected to broaden brand awareness, attract new customers and create additional growth opportunities across the region.
Shake Shack Partners With Bold Hospitality for Brazil ExpansionUnder the agreement, Shake Shack plans to develop 40 locations across Brazil by 2036, with its first restaurant scheduled to open in São Paulo in 2027. The planned rollout is expected to deepen the company's presence in Latin America while creating a new avenue for long-term licensing revenues.
Bold Hospitality Company, a São Paulo-based hospitality operator, brings extensive experience in Brazil's restaurant industry. The company operates brands such as Outback Steakhouse, Abbraccio and Aussie and expects to end 2026 with 217 restaurants across 22 states and the Federal District.
The partnership will combine Shake Shack's premium fast-casual positioning with Bold Hospitality's local market expertise and established restaurant operations. Shake Shack also plans to work with Brazilian producers and suppliers to deliver its signature offerings, including ShackBurger, Chicken Shack, crinkle-cut fries and frozen custard, while incorporating local flavors.
International Expansion Supports SHAK's Growth StrategyThe Brazil agreement aligns with Shake Shack's broader strategy of accelerating global development through licensing partnerships. The company operates more than 740 locations worldwide, including approximately 475 across 36 U.S. states and the District of Columbia and more than 265 international locations.
The licensed business continues to support the company's expansion efforts. In the second quarter of 2026, licensing revenues increased 7.1% year over year to $14.2 million, while total licensing sales rose 7.6% to $222.4 million. Shake Shack opened eight net new licensed restaurants during the quarter and continues to target 40-45 licensed openings for 2026. Management highlighted strong licensed-business performance in Canada, the United Kingdom and parts of China, despite geopolitical disruptions affecting operations in the Middle East.
Shares of SHAK have gained 13.9% in the past three months against the Zacks Retail - Restaurants industry’s 14.9% dip. Shake Shack continues to benefit from restaurant expansion, positive traffic trends, digital engagement and a growing international footprint. However, elevated beef prices, higher operating costs and intense competition remain concerns. Geopolitical instability in the Middle East also continues to pressure licensed operations.
Image Source: Zacks Investment Research
SHAK’s Zacks Rank & Other Key PicksCurrently, Shake Shack carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks from the Zacks Retail-Wholesale sector are:
Five Below, Inc. (FIVE - Free Report) currently sports a Zacks Rank #1 (Strong Buy). The company delivered a trailing four-quarter earnings surprise of 68.3%, on average. FIVE stock has gained 8.5% year to date. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Five Below’s fiscal 2027 sales and EPS indicates growth of 20.1% and 57.6%, respectively, from the year-ago period’s levels.
Cracker Barrel Old Country Store, Inc. (CBRL - Free Report) currently flaunts a Zacks Rank #1. The company delivered a trailing four-quarter earnings surprise of 228.6%, on average. CBRL stock has surged 122% year to date.
The Zacks Consensus Estimate for Cracker Barrel's 2026 sales and EPS indicates a year-over-year decline of 1% and 81.3%, respectively, from the prior-year levels.
FIGS, Inc. (FIGS - Free Report) has a Zacks Rank #2 at present. The company delivered a trailing four-quarter earnings surprise of 201.8%, on average. FIGS stock has risen 23.8% year to date.
The Zacks Consensus Estimate for FIGS’ 2026 sales and EPS indicates growth of 19.8% and 89.5%, respectively, from the prior-year levels.
JB Hunt očekává za čtvrtletí zisk na akcii (EPS) ve výši 1,95 USD, což představuje meziroční nárůst o 10,8 %, a tržby ve výši 3,55 miliardy USD, tedy růst o 16,4 %.
JB Hunt (JBHT - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on October 15, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis trucking and logistics company is expected to post quarterly earnings of $1.95 per share in its upcoming report, which represents a year-over-year change of +10.8%.
Revenues are expected to be $3.55 billion, up 16.4% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 5.37% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for JB Hunt?For JB Hunt, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -6.99%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that JB Hunt will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that JB Hunt would post earnings of $1.71 per share when it actually produced earnings of $1.91, delivering a surprise of +11.70%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
JB Hunt doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
3 Fresh Stock Buybacks: These are the Ones to BuyHelen of Troy NASDAQ: HELE reported fiscal second-quarter 2027 results that met its sales outlook and exceeded its adjusted earnings expectations, aided by growth in its Home & Outdoor segment, improving cash flow and a net benefit from tariff refunds that the company plans largely to reinvest.
Chief Executive Officer Scott Uzzell said the company remains focused on a multiyear effort to strengthen its operating foundation before pursuing broader growth. “Our recovery will not be linear,” Uzzell said, describing fiscal 2027 as a year for demonstrating progress in brand growth, marketplace execution, organizational capabilities and balance-sheet discipline.
Get Helen of Troy alerts:
Sales growth led by Home & Outdoor Helen of Troy and NanoString Technologies Trade Set-ups Consolidated sales increased 2.1% in the second quarter, in line with management’s outlook. Home & Outdoor sales rose 9.2%, with growth across Osprey, OXO and Hydro Flask. Beauty & Wellness sales declined 4.5%, as growth in wellness and nail care was more than offset by declines across the remainder of the Beauty business.
Uzzell said Osprey again led growth within Home & Outdoor, supported by consumer demand, product introductions and improvements in international distribution. OXO benefited from inventory-composition actions, distribution gains and new products, while Hydro Flask was aided by inventory actions, innovation and a partial recovery of tariff-related disruption in its corporate channel.
Helen Of Troy Is What We Fear Most About Q2 Earnings International sales rose 3.7%, led by Hydro Flask, OXO and Osprey. The company cited new products, expanded distribution and improved execution in selected markets, including a new Australian distributor.
Within Beauty & Wellness, management highlighted growth at Vicks and Braun, supported by distribution gains, comparisons with prior tariff-related items and new products. Olive & June also posted another solid quarter, driven by consumer demand, replenishment orders and new or expanded distribution.
However, Uzzell said some Beauty brands continue to face softer demand and require additional work on commercial execution and demand creation. During the quarter, the company appointed a new leader for the Beauty & Wellness business.
Tariff refunds lift profitability, fund reinvestment Chief Financial Officer Brian Grass said second-quarter results included approximately $26.9 million of gross pretax tariff refunds. After planned reinvestment, the company recorded an estimated net pretax benefit of about $4 million, equal to roughly $0.12 per diluted share after tax.
For the full fiscal year, Helen of Troy expects gross refunds covering the full amount of paid IEEPA tariffs of $80.5 million. The company plans to reinvest between $66.5 million and $70.5 million, resulting in an estimated net pretax benefit of $10 million to $14 million and an adjusted diluted EPS benefit of $0.30 to $0.45.
Management said it intends to use the funds for foundational and longer-term investments, including brand-building, product development, packaging, consumer insights, growth strategy and inventory cleanup. Grass said about 25% of the spending is expected to generate a fiscal 2027 return, while other investments are intended to better position the company for fiscal 2028.
Grass cautioned that the refunds do not fully offset the broader cumulative impact of tariffs. The company has also faced unreimbursed tariffs, supply-chain diversification expenses, longer lead times, disruption to certain revenue streams and higher interest expense associated with cash tariff payments.
Consolidated gross margin increased 800 basis points to 52.2%. The company attributed approximately 560 basis points of the gain to tariff refunds net of higher tariff costs, along with lower retail trade and promotional spending. These benefits were partly offset by inflation in commodities, fuel, freight, currency and supply availability, as well as less favorable inventory obsolescence.
The SG&A ratio increased 540 basis points to 46.4%, reflecting tariff-refund reinvestment, spending on the organization, go-to-market structure and brands, as well as higher packaging costs and divestiture litigation costs. Adjusted EBITDA increased $13.2 million, while adjusted EBITDA margin improved 280 basis points.
Balance sheet improves as inventory and debt decline Helen of Troy generated $56.5 million in cash flow from operations and $38 million in free cash flow during the first half. Inventory ended the quarter at $480 million, down $49 million from a year earlier. The percentage of active inventory improved by seven percentage points in the first half, and management is targeting a 12-percentage-point improvement by year-end.
Total debt fell to $673 million, down $221 million from the prior-year period and $108 million since the beginning of the fiscal year. Net leverage declined to 3.0 times from 3.5 times at the end of the first quarter. The company now expects to end fiscal 2027 with net leverage of 2.7 times or lower.
Full-year outlook revised The company narrowed its fiscal 2027 net sales outlook to $1.768 billion to $1.822 billion. It expects Home & Outdoor sales of $851 million to $876 million and Beauty & Wellness sales of $917 million to $946 million.
Base-business adjusted EBITDA guidance was maintained at $193 million to $196 million. Consolidated adjusted EBITDA guidance was raised to $203 million to $210 million, including the net tariff-refund benefit. Base-business adjusted EPS guidance was narrowed to $3.30 to $3.70. Consolidated adjusted EPS guidance was raised to $3.60 to $4.15. Free cash flow guidance was raised to $120 million to $140 million, despite a $9 million increase in planned capital expenditures. For the third quarter, Helen of Troy expects sales of $478.3 million to $504.5 million and consolidated adjusted EPS of $2.05 to $2.40. That estimate includes a projected tariff-refund benefit of $0.66 to $0.77 per share, as the company expects to recognize its remaining $51.8 million in gross IEEPA tariff refunds during the quarter.
Management said the outlook reflects continuing inflationary and supply-disruption risks related largely to conflict in the Middle East, as well as elevated fuel costs, higher interest and mortgage rates, discretionary-category softness, cautious retailer inventory management and a more promotional competitive environment.
Uzzell said the company remains confident in its strongest brands but expects a challenging consumer environment. He said Hydro Flask faces a more saturated and promotional beverageware market, while management seeks to maintain the brand’s premium positioning through consumer messaging, product innovation and expansion into adjacent categories.
About Helen of Troy (NASDAQ:HELE)Helen of Troy Limited is a global consumer products company that develops, markets and distributes branded products across the home and outdoor, beauty, and health and wellness categories. Its portfolio includes household and organization products, drinkware and outdoor equipment, personal-care appliances, hair-care products, and consumer health products.
The company's principal brands include OXO, Hydro Flask, Osprey, Drybar and Hot Tools. Helen of Troy also markets certain health and wellness products under licensed brands, including Vicks, Braun and Honeywell, as well as beauty products under selected licensed and owned brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Helen of Troy Right Now?Before you consider Helen of Troy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helen of Troy wasn't on the list.
While Helen of Troy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
10x Genomics navázala spolupráci s Fred Hutchinson Cancer Center s cílem hledat biomarkery rakoviny močového měchýře a detekovat reziduální onemocnění u AML.
Key Takeaways 10x Genomics partners with Fred Hutch to advance biomarker discovery in bladder cancer and AML detection.TXG will use Flex Apex and Xenium to study tumor biology and identify markers linked to treatment response.The collaboration aims to improve AML residual disease detection and expand clinical use of 10x's platforms. 10x Genomics, Inc. (TXG - Free Report) recently announced a multi-project research collaboration with Fred Hutchinson Cancer Center to advance single-cell and spatial technologies across solid tumors and blood cancers. The collaboration will focus on biomarker discovery in advanced bladder cancer and residual disease detection in acute myeloid leukemia (AML), marking 10x Genomics’ first clinical research initiative extending into hematologic malignancies.
Per management, cancer care has more effective therapies than ever, but there remains a significant need to better identify which treatments will benefit individual patients. 10x Genomics believes single-cell and spatial biology can provide direct insights into the biology that drives treatment response in tumors and blood, supporting the advancement of precision oncology.
TXG Stock Trend Following the NewsFollowing the announcement, TXG stock lost 5.6% at yesterday’s close. Year to date, the stock skyrocketed 366.6%, outperforming the industry’s 15.9% growth and the S&P 500’s 14.5% gain.
The collaboration could strengthen TXG’s long-term growth opportunity by expanding the use of its technology into clinically relevant applications where precise biological information may improve treatment decisions. Successful research outcomes could increase demand for 10x’s platforms among cancer centers and pharmaceutical researchers while creating additional opportunities for biomarker development and clinical testing. The initiative may also help demonstrate the commercial value of TXG’s technology beyond traditional research applications.
TXG currently has a market capitalization of $10.51 billion.
Image Source: Zacks Investment Research
More on the NewsThe bladder cancer project will use TXG’s Flex Apex and Xenium platforms, with plans to incorporate Atera, to examine tumor samples from patients receiving antibody-drug conjugates, immune checkpoint inhibitors and other therapies. Researchers will evaluate drug-target expression and tumor-microenvironment characteristics to identify biological markers associated with treatment response and clinical outcomes.
A second project will investigate whether Flex Apex-based single cell analysis can improve residual disease detection in AML. Current monitoring relies on multiple technologies, creating an opportunity for an integrated approach to identifying residual leukemic cells following treatment.
The collaboration also supports 10x Genomics’ broader efforts to build evidence for clinical applications of its single-cell and spatial technologies. Together with the company’s planned CLIA-certified laboratory, the initiative is expected to contribute to a framework for clinical reporting and help define how cellular and spatial data could support treatment planning in oncology and autoimmune disease.
Industry Prospects Favoring the MarketGoing by the data provided by Grandview Research, the global single-cell analysis market is estimated to reach $6.5 billion in 2026 and is projected to witness a CAGR of 21.7% through 2033.
Factors like the growing number of drug discovery activities, technological advancements in genomics and cell analysis tools, and rising demand for precision medicine and oncology research are boosting the market’s growth.
Other News10x Genomics recently announced Sentira, a new cloud-based computational platform designed to simplify and accelerate analysis of single-cell and spatial biology data. Its Sentira Spatial Analysis uses NVIDIA-accelerated computing to reduce processing times from hours to minutes. The platform is currently in early access and is expected to launch commercially in early 2027.
10x Genomics recently began commercial shipments of Atera, its next-generation spatial biology platform designed to combine whole-transcriptome analysis, sub-cellular resolution and single-cell sensitivity at scale. Demand for Atera has exceeded the company’s initial 2026 shipment expectations, with booked orders surpassing 40 instruments.
Some better-ranked stocks from the broader medical space are OPKO Health (OPK - Free Report) , Globus Medical (GMED - Free Report) and Merit Medical Systems (MMSI - Free Report) .
OPKO Health, currently flaunting a Zacks Rank #1 (Strong Buy), reported a second-quarter 2026 adjusted loss of 1 cent per share, which surpassed the Zacks Consensus Estimate by 87.5%. Revenues of $163.6 million beat the Zacks Consensus Estimate by 24.7%. You can see the complete list of today’s Zacks #1 Rank stocks here.
OPK has an estimated earnings growth rate of 23.3% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 95.1%.
Globus Medical, currently carrying a Zacks Rank #2 (Buy), reported a second-quarter 2026 adjusted EPS of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Merit Medical Systems, carrying a Zacks Rank #2 at present, reported second-quarter 2026 adjusted EPS of $1.19, which beat the Zacks Consensus Estimate by 23.9%. Revenues of $418.8 million surpassed the Zacks Consensus Estimate by 3.5%.
MMSI has an estimated long-term earnings growth rate of 10.4%. MMSI’s earnings surpassed estimates in the trailing four quarters, the average surprise being 14.1%.
Wall Street analysts forecast that Domino's Pizza (DPZ - Free Report) will report quarterly earnings of $4.33 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $1.17 billion, exhibiting an increase of 1.6% compared to the year-ago quarter.
Over the last 30 days, there has been an upward revision of 1.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Domino's Pizza metrics that are routinely monitored and predicted by Wall Street analysts.
It is projected by analysts that the 'Revenues- U.S. franchise advertising' will reach $132.10 million. The estimate suggests a change of +0.4% year over year.
The consensus estimate for 'Revenues- U.S. Company-owned stores' stands at $64.40 million. The estimate points to a change of -22.2% from the year-ago quarter.
Based on the collective assessment of analysts, 'Revenues- Supply chain' should arrive at $725.99 million. The estimate suggests a change of +4.2% year over year.
According to the collective judgment of analysts, 'Revenues- International franchise royalties and fees' should come in at $78.51 million. The estimate points to a change of -0.1% from the year-ago quarter.
Analysts forecast 'Store counts - Total U.S. Stores' to reach 7,263 . Compared to the current estimate, the company reported 7,090 in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Same store sales growth - U.S. stores' will likely reach 1.1%. The estimate compares to the year-ago value of 5.2%.
The consensus among analysts is that 'Store counts - Total' will reach 22,740 . Compared to the present estimate, the company reported 21,750 in the same quarter last year.
The collective assessment of analysts points to an estimated 'Store counts - International Stores' of 15,477 . Compared to the present estimate, the company reported 14,660 in the same quarter last year.
The average prediction of analysts places 'Store counts - U.S. Franchise Stores' at 7,075 . The estimate compares to the year-ago value of 6,830 .
Analysts expect 'Store counts - U.S. Company-owned Stores' to come in at 188 . Compared to the current estimate, the company reported 260 in the same quarter of the previous year.
Analysts' assessment points toward 'Store counts - Opened - International Stores' reaching 217 . Compared to the present estimate, the company reported 220 in the same quarter last year.
Analysts predict that the 'Store counts - Opened - Total U.S. stores' will reach 33 . The estimate compares to the year-ago value of 30 .
View all Key Company Metrics for Domino's Pizza here>>>
Shares of Domino's Pizza have experienced a change of -5.7% in the past month compared to the +1.4% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), DPZ is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Pagaya v roce 2026 zvýšila objem emisí ABS nad 9 mld. USD, přestože rozšiřuje alternativní způsoby financování; sekuritizace tak zůstává jejím klíčovým zdrojem financování.
Key Takeaways Pagaya raised $3.7B across six ABS deals in Q2'26 and added 11 institutional investors.PGY secured major auto, personal-loan and receivables facilities to broaden funding flexibility.Pagaya's 2026 ABS issuance topped $9B, showing securitization remains central to its funding model. Pagaya Technologies (PGY - Free Report) is steadily broadening its funding base, which could make its capital model more resilient. In second-quarter 2026, it raised $3.7 billion across six asset-backed securities (ABS) transactions and added 11 new institutional investors, taking the total to 174. At the same time, the company is expanding committed-capital structures outside traditional securitization markets, improving funding flexibility and visibility.
Recent transactions reinforce this shift. Pagaya secured up to $700 million in auto funding from Neuberger Specialty Finance, a nearly $700-million Variable Funding Note facility with ATLAS SP Partners and a $460-million revolving personal-loan facility expected to support about $850 million in capital deployment. It also expanded its ALPF receivables facility to $100 million. Together, these arrangements broaden funding flexibility and reduce reliance on the timing of public securitizations.
That flexibility could become increasingly important as Pagaya scales across personal loans, auto and point-of-sale financing. Its auto business reached an annualized network-volume run rate of $4.8 billion in the second quarter, while total quarterly network volume was $3.5 billion. Management has indicated that a growing portion of funding now comes through non-prefunded structures, including forward-flow and revolving arrangements. A broader mix of committed funding sources could help Pagaya better match different asset classes with different pools of institutional capital and reduce execution risk during periods when securitization spreads widen or investor demand weakens.
However, the company is not moving away from ABS in any meaningful sense yet. A few days ago, Pagaya completed a $600-million AAA-rated personal-loan securitization, lifting 2026 ABS issuance to more than $9 billion, including more than $6 billion tied to personal loans. The transaction drew 47 investors, including three new participants, underscoring continued demand for Pagaya-backed assets. Importantly, some of the newer funding structures are designed to bridge loans into eventual securitizations, meaning they can support the ABS model rather than substitute for it.
Hence, Pagaya appears to be building a more diversified funding architecture rather than replacing securitization. Forward-flow agreements, revolving facilities and warehouse-style structures should improve capital availability and reduce funding concentration risk, which is constructive for growth and execution. Still, record ABS issuance shows that securitization remains a core funding engine.
Comparing Pagaya’s Business Model With PeersLike PGY, Upstart Holdings, Inc. (UPST - Free Report) is an artificial intelligence (AI)-based lending platform that aspires to become capital-light but often holds loans on its balance sheet temporarily. The company’s core business model involves finding financing for loans after its network of bank and institutional partners originates them.
Upstart partner banks can finance the loan by keeping it on their balance sheet. The bank can sell the whole loan on Upstart’s platform or use forward flow agreements from institutions that commit to buying a specific volume or type of loan originated on the Upstart platform in the future.
Upstart also uses securitization, wherein pools of loans are bundled together and sold as ABS to institutional investors. However, the firm frequently reverts to a balance-sheet-heavy model, especially in tight liquidity markets, making it more volatile and exposed to macro cycles.
Another close competitor of PGY is LendingTree (TREE - Free Report) . But unlike PGY, LendingTree is a marketplace platform, not a lender. It matches consumers with financial product providers like mortgages, personal loans, credit cards and insurance.
LendingTree does not underwrite, originate or hold loans. Hence, its balance sheet is not credit-heavy. TREE’s balance sheet is detached from revenue generation. The company is primarily structured to support a fee-based digital marketplace, not balance sheet lending.
PGY’s Price Performance, Valuation & Estimate AnalysisOver the past six months, Pagaya shares have gained 51.9%, outperforming the industry’s growth.
Image Source: Zacks Investment Research
The stock is currently trading at a 12-month forward price-to-sales of 0.94X, which is below the industry average of 2.70X.
Image Source: Zacks Investment Research
Over the past seven days, the Zacks Consensus Estimate for PGY’s 2026 and 2027 earnings has been unchanged at $3.68 and $4.13, respectively. The consensus estimate indicates 11.2% and 12.2% year-over-year growth for 2026 and 2027, respectively.
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NuScale Power Corporation ("NuScale" or the "Company") (NYSE: SMR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether NuScale and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On September 11, 2026, UBS downgraded NuScale from "Neutral" to "Sell" and lowered its price target from $10 to $6. UBS analyst Jon Windham opined that NuScale is rapidly losing its "first-mover" advantage in small modular reactor (SMR) technology to faster-moving competitors. UBS also flagged a lengthy five-year build timeline, a critical lack of firm customer commitments, and projected a massive $700 million in negative free cash flow between 2026 and 2028. The report also described stagnating progress regarding NuScale's key RoPower project in Romania and its partnership with the Tennessee Valley Authority (TVA).
On this news, NuScale's stock price fell $1.60 per share, or 15.67%, to close at $8.61 per share on September 11, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Nebius ve 2. čtvrtletí zvýšil tržby o 454 % na 582,3 mil. USD a překonal konsenzus, ale vykázal čistou ztrátu 190,4 mil. USD při plánovaných kapitálových výdajích 20–25 mld. USD.
Nebius has already signed tens of billions in AI compute contracts, crushed revenue estimates, and handed investors a triple-digit return this year, but its balance sheet carries threats that could unwind everything before 2027 arrives.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) trades at $237.15. The AI cloud provider is converting a $37.49 billion contract backlog into revenue rapidly, giving investors direct exposure to AI compute demand outside mega caps.
Nebius leases GPU compute, storage and inference tools through Nebius AI Cloud, which produced 98% of group revenue last quarter. Anchor contracts include a $27 billion five-year Meta Platforms (NASDAQ:META) agreement and a Microsoft (NASDAQ:MSFT) deal valued at $17.4 billion to $19.4 billion. NVIDIA (NASDAQ:NVDA) committed $2 billion strategically. Shares are up 183.32% year to date but fell 5.09% in the latest session.
A Sold-Out Cloud With Rising Prices Points Higher Second-quarter revenue rose 454% to $582.3 million, beating the $574.65 million consensus. Group adjusted EBITDA came in at $236 million with a 41% margin versus a $21 million loss a year earlier. Management confirmed its $7 billion to $9 billion ARR target for 2026 and raised its year-end contracted power goal to 5 gigawatts.
Pricing power is growing. The company’s first capacity auction cleared 15% above its previous top price. At a forward P/E of 46 and consensus 2027 revenue of roughly $12.3 billion, the valuation leans on expected growth.
Billions in Capex and Convertible Debt Threaten Shareholders Nebius posted a GAAP net loss of $190.4 million. Consensus EPS is -$2.2773 for 2026 and -$5.6426 for 2027. Capex guidance is $20 billion to $25 billion, and quarterly interest expense rose to $119.1 million from $4.8 million.
Convertible debt has a fair value of $20.8 billion against a $8.5 billion carrying amount, which points to heavy potential dilution. Three customers made up for 24%, 21%, and 14% of revenue. In the first quarter, revenue fell short of estimates by 32.74%. At 50 times sales, the stock cannot afford another miss.
Third-Quarter Results Will Test Whether Growth Can Fund Itself The case for patience rests on operations working while profits remain a forecast. Nebius sells out new capacity as it comes online and expects more than $9 billion in customer prepayments this year. GAAP losses continue, though, and the company carries $12.1 billion in future lease obligations.
Consensus calls for about $904 million in third-quarter revenue. A beat and solid 2027 outlook would strengthen the bull case. A miss or new convertible offering would strengthen the bear case.
Wall Street Sees Upside After a Market-Beating Run Nebius trades at $237.15. The consensus target of $282.53 implies 19.1% upside. Price targets are uncertain, and this one reflects 10 analysts:
Strong Buy: 2 Buy: 6 Hold: 1 Sell: 1 The stock has gained 101.49% over the past year versus 16.16% for the S&P 500. Year to date, Nebius is up 183.32% compared with a gain of 13.98% for the index. Momentum has slowed. Over the past week, Nebius gained 0.54% versus 1.92% for the index. Shares remain below their 52-week high of $299.86.
Nebius Faces Its Biggest Test as 2027 Pricing Comes Into Focus At $237.15, Nebius trades below its consensus target.
The path to a higher stock price runs through the next three quarters. Capacity installed late in the second quarter starts adding revenue in the third. Deals signed at yields above $20 million per megawatt, with payback periods under two years, start coming online in late Q4. Vera Rubin systems should begin deploying in late 2026 or early 2027.
Customer prepayments cover 50% to 60% of related capex, reducing the need for new equity. With shares trading well below their high as margins expand, the outlook depends on execution.
The thesis fails if third-quarter revenue misses, a top customer pulls back or Nebius issues another large convertible. Watch progress toward the ARR target.
Nebius offers scaled, pure-play access to AI compute demand outside the chipmakers, and the current price reflects a backlog of more than $37 billion (we featured seven other non-chipmaker suppliers riding the same expansion, accessible without charge at here).
Contact [email protected] for any questions or corrections.
BlackSky získala pilotní kontrakt v hodnotě stovek tisíc dolarů na poskytování satelitních snímků Gen-3 novému zahraničnímu zákazníkovi ze zpravodajské oblasti.
BlackSky Wins Six-Figure Gen-3 On-Demand Pilot Contract with New International Intelligence Customer BlackSky Technology Inc. (NYSE: BKSY) won a six-figure Gen-3 On-Demand pilot imagery services contract with a new international intelligence customer, expanding the company’s operational footprint with a major sovereign partner in a critical strategic region.
“The rapid adoption of our advanced Gen-3 capabilities underscores a fundamental shift in how global defense and intelligence ministries utilize commercial space-based assets,” said Brian O’Toole, BlackSky CEO. “By delivering best-in-class 35-centimeter resolution imagery with the flexibility and agility of BlackSky Spectra, we are providing strategic and tactical ISR services at industry leading speed and scale for decision superiority. Our fully automated, low-latency architecture compresses the decision loop, providing the highest-quality, time-diverse data exactly when and where it’s needed most to mitigate operational ambiguity.”
Under the new short period-of-performance contract, the intelligence agency will gain flexible, global very high-resolution tasking capacity to monitor multiple locations with exceptional clarity. The integrated service feeds automated intelligence directly into cross-domain secure workflows, leveraging a growing constellation of operational Gen-3 satellites.
BlackSky's continued international expansion aligns with its established “land-and-expand” business strategy as Gen-3 pilot programs quickly scale into major, multi-year subscription commitments. As fast-moving geopolitical environments drive national security requirements, defense and intelligence customers are increasingly prioritizing immediate access to advanced commercial space-based intelligence capabilities as they develop sovereign systems. Because very high-resolution electro-optical imagery remains a scarce commodity globally, international entities are moving quickly to secure tasking capacity when and where they need it.
BlackSky’s vertically integrated satellite manufacturing and AI-driven software architecture offers secure, flexible access to imagery and AI-analytics through On-Demand and Assured subscription services or full sovereign systems. BlackSky maintains a steady deployment schedule for Gen-3 with plans for additional satellites on orbit by the end of 2026 that will continue to boost capacity, increase revisit rates and compress delivery timelines.
About BlackSky
BlackSky is a real-time, space-based intelligence company that delivers on-demand, high frequency imagery, analytics, and high-frequency monitoring of the most critical and strategic locations, economic assets and events in the world. BlackSky owns and operates one of the industry’s most advanced, purpose-built commercial, real-time intelligence systems that combines the power of the BlackSky Spectra® tasking and analytics software platform and our proprietary low Earth orbit satellite constellation.
With BlackSky, customers can see, understand and anticipate changes for a decisive strategic advantage at the tactical edge, and act not just fast, but first. BlackSky is trusted by some of the most demanding U.S. and international government agencies, commercial businesses, and organizations around the world. BlackSky is headquartered in Herndon, VA, and is publicly traded on the New York Stock Exchange as BKSY. To learn more, visit www.blacksky.com and follow us on X.
Forward-Looking Statements
Certain statements in this press release may contain forward-looking statements within the meaning of the federal securities laws with respect to BlackSky. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document. If any of these risks materialize or underlying assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. In addition, forward-looking statements reflect our expectations, plans, or forecasts of future events and views as of the date of this communication. We anticipate that subsequent events and developments will cause their assessments to change.
Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Additional risks and uncertainties are identified and discussed in BlackSky’s disclosure materials filed from time to time with the SEC which are available at the SEC’s website at http://www.sec.gov or on BlackSky’s Investor Relations website at https://ir.blacksky.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261008849549/en/
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Applied Digital má nasmlouvané výnosy v hodnotě 36 mld. USD z kapacity 1,41 GW, ale její růst závisí na financování a dokončení rozestavěných projektů AI.
Key Takeaways APLD's $36B contracted revenue base spans 1.41 GW across five campuses, backed by long-term leases.APLD expects over 600 MW online within 12 months, following a 322% surge in fiscal first-quarter revenues.APLD faces financing and construction risks, while Core Scientific and TeraWulf intensify competition. Applied Digital (APLD - Free Report) has a substantial foundation for long-term growth from its $36 billion contracted revenue base, provided it can convert contracted capacity into operating assets and recurring revenues. As of Aug. 31, 2026, APLD had approximately 1.41 GW of contracted critical IT load across five campuses, representing about $36 billion of contracted revenues over initial base terms. The portfolio is backed by CoreWeave and investment-grade hyperscalers, with leases generally structured for 15 years and on a take-or-pay basis.
The company is beginning to demonstrate this conversion. Polaris Forge 1 reached 250 MW of operational capacity on Oct. 1, while APLD expects to place more than 600 MW into service over the next 12 months. First-quarter fiscal 2027 revenues surged 322% year over year to $341.9 million, while HPC Hosting generated $262.6 million, including $65.8 million of base rent.
However, investors should not equate the backlog with immediately realized revenues. Much of the contracted capacity remains under construction, while APLD had $6.4 billion of debt and $3.7 billion in cash, cash equivalents and restricted cash at quarter-end. Customer concentration and construction and financing requirements remain important risks.
Overall, APLD's $36 billion contracted revenue base can support long-term growth, but sustained growth depends on successfully financing, completing and bringing contracted AI capacity online while increasing recurring base-rent revenues. The growth outlook is also reflected in the Zacks Consensus Estimate, which projects for fiscal 2027 and 2028 revenue growth of 49.67% and 107.93%, respectively, underscoring the potential for APLD's expanding AI infrastructure portfolio to translate its contracted revenue base into substantial top-line growth.
APLD Faces Stiff Competition in Contracted Revenue BaseCore Scientific (CORZ - Free Report) is narrowing APLD’s contracted-revenue lead, with more than $24 billion in contracted revenues and about 1.1 GW of contracted capacity. Core Scientific also added an AMD agreement representing over $14 billion of base contracted revenues across 15 years. With expansion potential beyond current commitments, Core Scientific presents a growing contracted-revenue challenge to APLD.
TeraWulf (WULF - Free Report) , meanwhile, is building substantial contracted visibility, reporting roughly $27 billion of contracted revenues and 839 MW of leased capacity. TeraWulf’s 401-MW Anthropic lease contributes approximately $19 billion over 20 years, and the company targets another 250-500 MW of annual contracted capacity growth. This combination gives TeraWulf a credible path to challenge APLD’s contracted-revenue growth narrative.
APLD’s Share Price Performance, Valuation & EstimatesShares of APLD have lost 2.9% year to date, underperforming the broader Zacks Finance sector’s 4.2% rise.
APLD’s YTD Price Performance
Image Source: Zacks Investment Research
From a valuation standpoint, APLD trades at a trailing twelve-month price-to-book (P/B) ratio of 4.02, higher than the Finance – Miscellaneous Services industry’s 2.96. The company carries a Value Score of F. A price-to-book ratio above 1.0 means the stock is trading at a premium to its accounting net worth.
APLD’s Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Applied Digital’s fiscal 2027 bottom line is currently pegged at a loss of $1.09 per share, unchanged over the past 30 days. The projected loss is wider than the 91-cent loss recorded a year ago.
Needham snížil cílovou cenu akcií Applied Digital (APLD) z 83 USD na 70 USD kvůli financování, přesto firma v prvním fiskálním čtvrtletí meziročně více než čtyřnásobně zvýšila tržby na 342 milionů USD.
Buy Applied Digital (APLD). Q1 showed real traction: revenue >4x YoY and only a 1-cent per-share loss, plus new 75MW capacity coming online. Needham cut the target mainly for financing/capex overhangs, which the market is already pricing—so the upside is in balance-sheet execution as lease cash flows start to stabilize. Thesis killer: A financing cycle forces repeated dilutive equity or covenant-driven restructuring before lease revenue meaningfully ramps, keeping the discount permanently.
Key Risk: Dilution or covenant trouble from continued expensive financing before lease cash flows ramp.
AI data-center lease beneficiaries
Buy a basket proxy for hyperscaler AI infrastructure demand: Equinix (EQIX). The news reinforces that hyperscalers keep demanding power-and-capacity buildout; EQIX is positioned to monetize that demand with more mature cash flows and less “build-and-fund” execution risk than APLD. Thesis killer: AI infrastructure demand slows or pricing power weakens, causing lease growth to disappoint and compress multiples.
Key Risk: AI data-center demand/pricing weakens enough to stall lease growth and compress margins.
Needham analyst John Todaro trimmed his price target on Applied Digital APLD on October 8th even though the AI infrastructure firm reported a blockbuster Q1 last evening.
The company more than quadrupled its revenue on a year-over-year basis to $342 million, on a per share loss of just one cent, miles above $116 million and 29 cents per share that analysts had called for.
Despite the remarkable print, Applied Digital shares are trading at less than half their price in late May.
Todaro trimmed his price target from $83 to $70 primarily to reflect near-term financing overhangs and capital expenditure risks.
While Applied Digital’s top-line growth was extraordinary, the infrastructure builder posted a net loss of $221 million due to rising interest expenses and heavy build-out costs across its data center campuses.
Funding massive HPC and AI capacity requires substantial debt and capital raises, which has kept retail and institutional investors cautious.
Needham adjusted its price objective on APLD stock to account for these elevated borrowing costs and potential dilution – acknowledging that sentiment remains heavily constrained by the balance sheet overhead required to bring new gigawatt capacity online.
Investors should note, however, that Needham’s downwardly revised $70 price target still signals potential upside of more than 200% in Applied Digital shares.
The investment firm maintained its “Buy” rating on the company – citing its expanding $36 billion lease pipeline and its crucial role in providing next-generation HPC infrastructure to hyperscalers.
APLD delivered the second 75-megawatt phase of Building 2 at its Polaris Forge 1 campus on Oct. 1st, proving that new data center capacity is coming online much faster than expected.
As long-term leases begin generating steady cash flows, Needham expects the market to eventually revalue the company like a stabilized digital infrastructure landlord.
APLD shares’ longer-term trajectory will now depend more on balance sheet execution.
Hyperscaler appetite for AI compute power is undeniable – but the Nasdaq-listed firm must show that contracted rental revenue will materialize fast enough to service its expanding debt load.
If management successfully converts its 1.41 gigawatt lease book into recurring operating cash flow without issuing dilutive equity, the stock’s steep valuation discount could disappear quickly.
Conversely, further debt rate pressure remains the primary swing factor keeping shares suppressed.
For long-term investors, the current sell-off presents a high-conviction risk-reward entry backed by fundamental multi-year demand drivers.
All in all, while not as bullish as Needham, other Wall Street firms are sticking with their bullish view on Applied Digital as well.
The consensus rating on APLD sits at Buy currently, with a mean price target of about $63, which suggests massive upside potential from here.
CoreWeave vybuduje v kampusu AdaniConneX Taloja v Indii AI datová centra o výkonu 240 MW; první fáze zahrnující tři budovy po 80 MW má zahájit provoz v polovině roku 2028.
Key Takeaways CoreWeave is entering India with 240 MW of AI data center capacity at AdaniConneX's Taloja campus.The project includes three 80 MW buildings, with the first phase expected to be operational in mid-2028.CoreWeave plans to deploy NVIDIA Vera Rubin, targeting agentic AI and inference workloads in India. CoreWeave, Inc. (CRWV - Free Report) recently took a major step in its global expansion strategy by entering India, announcing plans to develop 240 MW of AI data center capacity through a collaboration with AdaniConneX at its Taloja campus in Navi Mumbai. The move comes as demand for AI computing infrastructure accelerates globally and India emerges as a booming market for AI development, cloud computing and data center investment. The expansion is likely to be a key growth catalyst for CoreWeave, but its benefits will depend on how quickly the company can bring capacity online, secure customers and monetize increasingly powerful AI infrastructure.
Per the deal, the initial deployment will consist of three 80 MW buildings, with CoreWeave serving as the sole tenant. The campus also has the potential to double capacity by another 240 MW, giving the company a possible total expansion opportunity of 480 MW. The first phase is expected to become operational in mid-2028, with additional capacity coming online in phases. A key aspect of the announcement is its plan to deploy the NVIDIA Vera Rubin Platform. Recently, CRWV expanded beyond GPUs with NVIDIA Vera and Vera Rubin, targeting agentic AI and inference workloads while deepening its infrastructure strategy. Deploying next-generation NVIDIA infrastructure in India could give customers access to advanced AI computing without requiring them to make massive upfront infrastructure investments.
CoreWeave has been aggressively building a global footprint across North America, Europe and the Asia-Pacific. The company's entry into Indonesia in August represents another step in that strategy. As stated on its second-quarter earnings call, CoreWeave has approximately 4.2 GW of contracted power. The India project is likely to fit into a broader strategy of secure power, build specialized data centers, deploy advanced NVIDIA hardware and provide AI infrastructure close to customers. The model can create a powerful competitive position if CoreWeave maintains high utilization and attractive pricing.
Mapping CRWV’s Competitive LandscapeNebius Group (NBIS - Free Report) recently acquired Inferize to strengthen production inference capabilities within Token Factory. Inferize aims to cut cold-start delays, reduce idle GPU time and improve capacity utilization. The deal adds GPU systems expertise as Nebius expands inference and post-training workloads. It plans to invest £1.7 billion in U.K. AI infrastructure, adding three advanced NVIDIA-powered deployments to support growing AI demand. NBIS recently partnered with Palantir for AI-native cloud infrastructure. Under the agreement, Nebius will provide AI compute and inference infrastructure to Palantir’s commercial customers. NBIS expects connected power capacity to reach roughly 800 MW to 1 GW by 2026 end.
Microsoft (MSFT - Free Report) continued expanding its partnerships across AI, cloud and enterprise technology. The company broadened its decade-long partnership with Databricks into the 2030s, while expanding ties with Mistral to bring its models across Microsoft Foundry, Copilot Studio and Azure. Microsoft also partnered with 3M on AI data-center infrastructure and enterprise transformation, with Azure set to deploy 3M’s Expanded Beam Optical technology. Its partnership with NASA entails applying AI tools to scientific data discovery. Microsoft also struck an AI content agreement with Nine Entertainment, allowing Copilot to reference its journalism, while its OpenAI relationship continues under an IP arrangement extending to 2032.
CRWV Price Performance, Valuation and EstimatesShares of CoreWeave have gained 23.5% year to date compared with the Internet Software industry’s rise of 7.6%.
Image Source: Zacks Investment Research
On a price-to-book basis, CRWV’s shares trade at 8.08X, higher than the Internet Software industry’s 5.44X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CRWV’s earnings for the current year has been revised downward over the past 60 days.
Image Source: Zacks Investment Research
CRWV currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Ředitel účetnictví společnosti Figma Tyler Herb prodal v rámci předem sjednaného plánu 10b5-1 1 418 akcií za průměrnou cenu 21,62 USD za akcii, celkem za 30 657,16 USD.
Figma, Inc. (NYSE:FIG – Get Free Report) CAO Tyler Herb sold 1,418 shares of Figma stock in a transaction on Monday, October 5th. The shares were sold at an average price of $21.62, for a total value of $30,657.16. Following the completion of the sale, the chief accounting officer directly owned 246,130 shares of the company’s stock, valued at approximately $5,321,330.60. This represents a 0.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Tyler Herb also recently made the following trade(s):
On Thursday, September 3rd, Tyler Herb sold 1,416 shares of Figma stock. The shares were sold at an average price of $26.29, for a total value of $37,226.64. On Thursday, August 27th, Tyler Herb sold 2,000 shares of Figma stock. The stock was sold at an average price of $30.00, for a total value of $60,000.00. On Friday, August 21st, Tyler Herb sold 1,840 shares of Figma stock. The stock was sold at an average price of $27.14, for a total value of $49,937.60. On Tuesday, August 4th, Tyler Herb sold 709 shares of Figma stock. The shares were sold at an average price of $26.00, for a total value of $18,434.00. On Monday, August 3rd, Tyler Herb sold 1,536 shares of Figma stock. The shares were sold at an average price of $26.00, for a total value of $39,936.00. Figma Price Performance NYSE FIG opened at $21.64 on Thursday. The company has a market cap of $9.85 billion, a P/E ratio of -5.95 and a beta of 1.32. Figma, Inc. has a 12 month low of $16.60 and a 12 month high of $71.48. The company has a 50-day moving average of $24.28 and a 200-day moving average of $22.04.
Figma (NYSE:FIG – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.30. Figma had a negative net margin of 123.15% and a negative return on equity of 100.03%. The business had revenue of $370.08 million for the quarter. During the same period in the prior year, the business posted $0.09 earnings per share. Figma’s revenue was up 48.2% on a year-over-year basis. As a group, equities research analysts anticipate that Figma, Inc. will post -0.75 EPS for the current year. Institutional Investors Weigh In On Figma Institutional investors have recently bought and sold shares of the business. Greylock XIV GP LLC purchased a new position in shares of Figma in the 2nd quarter valued at $1,056,824,403. SC US Ttgp LTD. increased its holdings in Figma by 5.8% in the 1st quarter. SC US Ttgp LTD. now owns 26,728,171 shares of the company’s stock valued at $565,034,000 after purchasing an additional 1,466,851 shares in the last quarter. Bank of America Corp DE increased its holdings in Figma by 428.1% in the 1st quarter. Bank of America Corp DE now owns 4,180,575 shares of the company’s stock valued at $88,377,000 after purchasing an additional 3,388,902 shares in the last quarter. Cosmic Management LLC acquired a new stake in Figma in the 4th quarter valued at $151,535,000. Finally, Index Venture Growth Associates V Ltd purchased a new position in Figma in the fourth quarter valued at about $87,780,000.
Analyst Upgrades and Downgrades Several analysts have recently issued reports on the stock. Citigroup boosted their price objective on shares of Figma from $35.00 to $37.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Bank of America increased their target price on Figma from $30.00 to $33.00 and gave the stock a “buy” rating in a research report on Wednesday, August 19th. KeyCorp assumed coverage on Figma in a research report on Monday, September 14th. They issued a “sector weight” rating on the stock. Weiss Ratings upgraded Figma from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. Finally, Wells Fargo & Company lowered their price target on Figma from $42.00 to $36.00 and set an “overweight” rating for the company in a research report on Friday, June 26th. Four equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Figma has an average rating of “Hold” and an average target price of $32.56.
Get Our Latest Research Report on Figma
Figma Company Profile (Get Free Report)
Figma, Inc is a collaborative software company that provides browser-based tools for designing, prototyping and developing digital products. Its platform enables product designers, developers, researchers, marketers and other stakeholders to work together on user interfaces and digital experiences in real time.
The company’s product portfolio includes Figma Design for interface design and prototyping, FigJam for collaborative brainstorming and whiteboarding, and Dev Mode, which helps developers inspect designs and translate them into working products.
See Also Five stocks we like better than Figma Skydance Just Became a Media Giant—With an $80 Billion Debt Load Could Velo3D Be the Next Defense Buyout Target? Penguin Solutions Is Soaring as AI Memory Demand Explodes Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Figma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Figma and related companies with MarketBeat.com's FREE daily email newsletter.
